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Abstract 
 
Two key proteins, LexA and RecA, are involved in regulation of the SOS expression 
system in bacteria. LexA and RecA act as the transcriptional repressor and inducer of the SOS 
operon, respectively. LexA downregulates the expression of at least 43 unlinked genes and 
activated RecA interacts with the repressor LexA and therefore, LexA undergoes self-cleavage. 
The ability of the LexA protein to dimerize is critical for its ability to repress SOS-regulated 
genes in vivo, as the N-terminal domain (NTD) alone has a lower DNA-binding affinity without 
the C-terminal domain (CTD) and the components for the dimerization of LexA are located in 
the CTD. Two antiparallel β-strands (termed β-11) in the CTD at the dimer interface of LexA 
are involved in the dimerization. LexA interacts with the active form of RecA in vivo during the 
SOS response. It was determined experimentally that monomeric and non-cleavable LexA 
binds more tightly to RecA and is resistant to self-cleavage. Therefore, we reasoned that if we 
can produce such LexA mutants we would be able to stabilize the LexA and active RecA 
complex for crystallization. Therefore, in this experiment, we attempted to make a non-
cleavable and predominantly monomeric LexA that interacts intimately with RecA. We 
produced four single mutations at the dimer interface of the non-cleavable and NTD-truncated 
mutant of LexA (∆68LexAK156A) in order to weaken the interactions at the interface. The 
predominant forms of LexA mutants and the affinities of interaction between the mutant LexA 
proteins and RecA were examined. ∆68LexAK156AR197P mutant was found as predominantly 
monomeric at a concentration of 33.3 μM both by gel filtration chromatography and dynamic 
light scattering (DLS) experiments. It also bound RecA more tightly than wild-type LexA. 
Another mutant, ∆68LexAK156AI196Y, was also found as predominantly monomeric at a 
concentration of 33.3 μM by DLS. Both these proteins were subjected to crystallization with 
wild-type RecA protein. We were able to produce some predominantly monomeric LexA with 
good binding affinity for RecA; however, we were unsuccessful in co-crystallization. 
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Chapter One:  Introduction 
Damage to the bacterial DNA by external agents such as ultra violet (UV) radiation can 
lead to ultimate cell death. Therefore, different DNA repair mechanisms have been developed 
by bacterial species to encounter the danger. The SOS response is such a coordinated cellular 
response to bacterial DNA damage. The expression of more than 40 genes in the SOS network 
is induced by DNA damage. Two key proteins, LexA and RecA, are involved in regulation of 
the expression system of the SOS operon (Courcelle et al., 2001a; Fernandez et al., 2000; 
Janion, et al., 2002; Walker, 1985; Witkin, 1991). LexA and RecA act as the transcriptional 
repressor and inducer of the SOS system, respectively. Under normal cellular conditions, the 
LexA protein binds to the operator region of SOS genes, called ‘the SOS box’, and 
downregulates the expression of at least 43 unlinked genes, including the lexA gene itself 
(Courcelle et. al., 2001a; Fernandez et al., 2000). Damage during DNA replication produces 
single-stranded DNA (ssDNA) at the lesion site, which initiates the SOS response mechanism. 
RecA, a bacterial recombinase protein, wraps around the ssDNA forming a nucleoprotein 
filament and becomes active in the presence of ATP. The active RecA nucleoprotein filament 
interacts with the repressor LexA protein. As a result of this interaction LexA is proteolytically 
cleaved in a RecA-dependent fashion. This action is defined as the co-protease activity of RecA 
(Horrii et al., 1981; Kowalczykowski et al; 1994; Little et al., 1980). As a result, the 
concentration of LexA in the cell drops approximately tenfold (~2 μM to ~0.2 μM) and SOS 
genes are derepressed (Sassanfar and Roberts, 1990). DNA polymerase V, an error prone 
bacterial replication machine, forms due to umuCD gene expression in the SOS operon. This 
DNA polymerase V repairs the lesion site by an error-prone DNA replication procedure. After 
the damage is repaired, the induction signal disappears and the cell returns to the normal 
conditions. The amount of LexA in the cell also returns to normal.   
The E. coli LexA repressor is a 22.7 kD protein and contains 202 residues (Little and 
Mount, 1982; Walker, 1985). It has two domains, an N-terminal DNA-binding domain (NTD, 
1-69 residues) and a C-terminal dimerization and catalytic domain (CTD, 75-202 residues) 
(Hurstle et al., 1986; Luo et al., 2001). A short hinge region joins the two domains. LexA 
usually remains in the dimeric form under normal cellular conditions. Again, the two-fold 
symmetry of the SOS box suggests that LexA binds DNA as a dimer. The ability of LexA 
 2 
 
protein to dimerize is critical for its ability to repress SOS-regulated genes in vivo, as the NTD 
alone has a lower affinity for DNA. Two monomers of LexA bind to the imperfect palindrome 
sequence of the DNA with their NTDs, which harbour a helix-turn-helix DNA-binding motif 
(Fogh et al., 1994; Knegtel et al., 1995). The two C-terminal domains (CTDs) from the two 
DNA-bound LexAs interact to form a dimer (Schnarr et al., 1988; Schnarr et al., 1985). The 
cleavage site, Ala84-Gly85, is also found in the C-terminal domain. Cleavage at this site 
separates the two domains and the LexA NTDs are split from the DNA-binding sequence. The 
SOS genes are thus derepressed and their expression occurs.  
LexA slowly undergoes auto-cleavage in solution (Little, 1984). Active RecA stimulates 
the latent capacity of LexA for auto-digestion (Little, 1991). Two residues of the CTD of LexA, 
Ser119 and Lys156, serve as the catalytic residues during the cleavage (Ser/Lys dyad). This 
dyad cleaves the peptide bond between Ala84 and Gly85. All the LexAs from different 
bacterial species and its homologues (UmuD and λ repressor, for example) contain these 
conserved residues. The Ser/Lys dyad model is supported by mutational studies of these 
residues (Lin and Little, 1989; Lin and Little, 1988; Slilaty and Little, 1987). Replacing either 
the Ser119 or Lys156 residues with Ala (S119A or K156A mutations) produces non-cleavable 
LexA. RecA does not directly participate in the chemistry of the cleavage reaction. Therefore, it 
is called ‘the co-protease’. 
RecA is bacterial recombinase protein that has at least three known functions: 
homologous recombination, co-protease activity and translesion synthesis. Almost all forms of 
organisms contain proteins from the recombinase family. During replication or DNA damage, 
RecA monomers polymerize around the ssDNA in the 5′-3′ direction, forming a nucleoprotein 
filament with ~6 (6.16) monomers per turn in the presence of ATP or its analogs (Chen et al., 
2008). ATP binding facilitates an allosteric conformational transition in RecA, which causes 
the RecA self-polymer to be stretched approximately 50-60% to make it a 93.96 Å pitch per 
turn. The RecA-bound DNA is also underwound to 18.5 base pairs (bp) per turn (Chen et al., 
2008; DiCapua et al., 1992; DiCapua et al., 1990; Nishinaka et al., 1997; Yu et al., 2001). This 
filament provides binding sites for other molecules (three DNA strands or proteins such as 
LexA). The dimer dissociation constant of LexA (Kdimer or Kd) in solution was reported to be in 
the picomolar range determining by experiments involving pressure-dependent changes in the 
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LexA intrinsic tryptophan (residue number 201, buried in the dimer interface) (Mohana-Borges 
et al., 2000), but was not confirmed by other experiments. If true, this indicates that the LexA 
interacts with the RecA-ssDNA complex as dimer rather than monomer; though historical 
findings suggest that the LexA monomer binds RecA tighter than the dimer (Schnarr et al., 
1988). However, the interactions of LexA with the RecA filament are hard to predict until a 
crystal structure of the complex is solved.  
Highly ordered arrangements of molecules, called crystals, are abundant in nature. 
Various kinds of small molecules and macromolecules form crystals spontaneously. Likewise, 
protein molecules also can be prompted to form crystals when placed in appropriate conditions. 
Crystals are composed of a repeating series of unit cells where proteins align themselves in a 
consistent orientation. The lattice thus formed during crystallization is held together by non-
covalent interactions (Rhodes, 1993). Protein crystals serve as a tool to solve three-dimensional 
structures via X-ray diffraction using a method called X-ray crystallography. RecA forms a 
self-polymer in a helical arrangement with or without DNA molecules. The two conformations 
of the RecA protein (compressed and extended) are quite different with regard to the helical 
pitch of the filaments. The active conformation has a helical pitch of ~94 Å (Chen et al., 2008; 
DiCapua et al., 1990; Flory et al., 1984; Morimatsu et al., 2000; VanLoock et al., 2003b; Yu et 
al., 2001) and inactive conformation has a pitch of ~82 Å (DiCapua et al., 1990; Flory et al., 
1984; Vanlook et al., 2003b; Yu et al., 2001). The active conformation of RecA has always 
been difficult to crystallize. Chen et al. (2008) instead solved the crystal structure by physically 
joining the RecA subunits. Therefore, we reasoned that a protein that binds intimately to RecA 
in its active conformation may be able to stabilize that active conformation during crystal 
packing. LexA protein interacts with the active form of RecA. Due to this interaction, we 
presumed that LexA can be used as a tool to stabilize the active RecA conformation during 
crystallization. This will also help in understanding the structural details of the co-protease 
activity of RecA. The difficulty in crystallizing the RecA-LexA complex is that active RecA 
mediates the autocleavage of wild-type LexA. Again, the LexA monomer binds more tightly to 
RecA than the dimer (Schnarr et al., 1988). However, in a co-crystallization trial of RecA and 
LexA, the protein concentration has to be around 1 mM. Again, the dimer dissociation constant 
(Kd) of LexA is in the picomolar range (Mohana-Borges et al., 2000). Because of these traits, 
 4 
 
LexA should predominantly exist as a dimer in co-crystallization experiments. Therefore, an 
attempt was previously undertaken in our lab to make a LexA mutant that is predominantly 
monomeric in solution, can tightly bind RecA and is resistant to auto-cleavage (Moya, 2006). 
Though it was possible to produce monomeric LexA mutants, the co-crystallization of LexA 
and RecA was unsuccessful. A crystal structure of the LexA dimer shows that interactions 
between the antiparallel β-11 strands at the dimer interfaces are favorable for dimer 
stabilization (Luo et al., 2001). Therefore, single mutations in the terminal residues of β-11 may 
produce monomeric LexA. In addition, the K156A mutation can make it non-cleavable. In this 
study, single mutations were introduced at three consecutive positions (residues 195 to 197) in 
the β-11 strands at the dimer interface of LexA in order to increase the Kd value to produce 
monomeric LexA. Their binding ability with RecA was also observed. Finally, the 
predominantly monomeric LexA forms found in the experiments were subjected to 
crystallization with RecA. 
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Chapter Two: Literature review 
2.1 LexA is a repressor protein 
Control of gene expression can be maintained at several points in living systems. 
Transcription initiation is a major control point of gene expression regulation. Recognition of 
the promoters by RNA polymerase can be inhibited or stimulated during transcription initiation. 
Many different kinds of regulatory molecules have been reported to enhance or reduce the 
stability of the transcription complex in prokaryotes (Browning and Busby, 2004). A bacterial 
protein, LexA, acts as this type of transcriptional regulator in bacterial cells. Under normal 
cellular conditions, LexA protein binds to the operator region of the SOS genes, called ‘the 
SOS box’, and downregulates the expression of at least 43 unlinked genes, including the lexA 
gene itself (Courcell et al., 2001a). SOS genes are expressed when the cell is threatened by any 
external agents and its DNA is damaged. With very few exceptions, LexA acts as a repressor 
protein of these genes found in a diverse range of bacteria.    
 
2.2 SOS transcriptional response 
The regulation of gene expression in response to different environmental conditions is 
necessary for the survival of the cell, as well as maintaining the structural and functional 
integrity of the genome. The SOS response is a coordinated cellular response to DNA damage 
and is found in most bacterial species. The Ames test, which is based on SOS mutagenesis, 
provided evidence about the relationship between bacterial DNA damage and the SOS response 
(Ames, 1973). The SOS response was first elaborately described in Escherichia coli (Walker, 
1984). However, this phenomenon was first proposed and named by Miroslav Radman in 1974 
(Radman, 1974). The SOS system is a programmed DNA repair regulatory network, which 
results in DNA mutagenesis and genetic exchange or recombination (Matic et al., 1995). This 
presumably helps the bacteria evolution, especially under stress (Radman et al., 1999). Stalled 
DNA replication and damage can occur through metabolic intermediates in the well-fed (Cox et 
al., 2000) or starved cells (Taddei et al., 1995). Exogenous treatments or agents that elicit DNA 
damage, or even the DNA replication fork can induce the SOS response in bacteria (Erill and 
Barbe, 2007; Kelley, 2006). 
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The interplay between two key regulatory proteins controls the SOS system. One of 
those proteins is the LexA repressor protein, which downregulates its own and several other 
proteins’ expression during normal cell growth (Courcelle, et al., 2001a; Fernandez et al., 
2000). The second is the inducer protein, RecA. RecA is a recombinase protein, which leads 
homologous DNA recombination in bacteria. The RecA protein becomes active by binding to 
single-stranded DNA in response to DNA damage or during homologous recombination and 
forms a nucleoprotein filament in the presence of ATP (Chen et al., 2008; Cox, 2007b). The 
ssDNA-RecA-ATP filament interacts with LexA and activates the self-cleavage activity of the 
LexA, which is also termed as ‘auto-cleavage’ (Little, 1991). RecA does not directly take part 
in the catalysis reaction and this is why RecA is also called the ‘co-protease’. Self-cleavage 
occurs between residue Ala84 and Gly85 of the C-terminal domain (CTD) of LexA and while 
this occurs LexA dissociates from the SOS boxes. This causes induction of the expression of 
SOS genes. The co-protease activity of the RecA protein disappears after the DNA damage is 
repaired and allows functional LexA to re-accumulate and bind to the target DNA sites to 
prevent further expression of the SOS genes (Erill and Barbe, 2007). 
 
2.2.1 Mechanism of the SOS mutagenesis 
The basal level of LexA in the cell is high enough to repress most of the SOS genes and 
lexA itself. Upon cleavage by the RecA protein, LexA cannot bind to the operator; therefore, 
several genes from the SOS regulon are expressed to perform error-prone DNA replication to 
repair the damage. After the damage repair, the number of LexA molecules increases and the 
SOS genes are again repressed. A cascade of three major repair processes takes place during the 
SOS response: excision, recombination and mutagenic repair. The DNA lesions are removed in 
the first step by nucleotide excision or base excision. Recombination, greatly aided by RecA 
induction, occurs next and the RecA concentration increases to at least 100,000 monomers in 
the cell. This recombinational repair lasts for about 30 minutes. However, not all the lesions are 
removed by recombinational repair. Therefore, mutagenic repair takes place. Finally, after 
completion of the damage repair, the SOS signals disappear and the SOS genes are again 
blocked by the LexA repressors. Cell division then resumes normally. Figure 2.1 shows 
different steps during this mutagenic DNA repair system.    
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Figure 2.1 SOS mutagenic DNA repair.  
 
The SOS mutagenesis is an error-prone DNA replication process that allows the bypass 
of DNA lesions induced by UV or other external agents via a special kind of DNA repair 
machinery (Walker, 1985). Transcriptional derepression of the SOS genes occurs at the 
initiation of this process, which includes cleavage of the LexA repressors by activated RecA 
nucleofilament at the umuCD operon.  
Two proteins, UmuD and UmuC, are expressed as a result of the induction of the 
umuCD operon. These proteins associate together and produce a heterodimer called 
UmuD2UmuC, which is responsible for the initiation of the DNA damage cell cycle check point 
(Opperman et al., 1999). Again, the activated RecA mediates the cleavage of UmuD (Figure 
2.1) (removal of N-terminal 24 amino acids) and produces UmuD′ to generate either an 
UmuD/UmuD′ heterodimer or an UmuD′2 homodimer (Burckhardt et al., 1988; Nohmi et al., 
1988; Shinagawa et al., 1988). The UmuD′2UmuC complex along with activated RecA 
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constitutes a functional DNA polymerase, known as DNA polymerase V (UmuD′2C-RecA-
ATP) (Figure 2.1) (Jiang et al., 2009; Reuven et al., 1999; Tang et al., 1999). DNA polymerase 
V is responsible for bypassing the DNA lesions (translesion synthesis) that cannot be replicated 
by DNA polymerase III (Figure 2.1) (Tang et al., 2000; Tang et al., 1998). When the lesions are 
repaired by base inclusions and there is no longer any ssDNA left, RecA loses its active 
conformation and cannot cleave UmuD anymore. Translesion synthesis is inhibited by the 
remaining UmuD′-UmuD heterodimers (Battista et al., 1990). They are eventually removed 
from the cell by the ATP-dependent protease, ClpXP, which shuts down the SOS mutagenesis 
process (Gonzalez et al., 2000). 
 
2.2.2 The SOS regulon 
The components and mode of regulation of the SOS response exhibit diversity among 
the different bacterial phyla (Mazón et al., 2004a). All Probacteria subclasses have a lexA-like 
gene except for Epsilonprobacteria (Erill and Barbe, 2007). A lexA-like gene is present in all 
Gram-positive bacteria (Erill and Barbe, 2007), Cyanobacteria (Mazón et al., 2004b) and Green 
nonsulfur bacteria (Fernandez et al., 2002). Genomic studies on the LexA or SOS regulons 
from four different bacteria, E. coli (Courcell et al., 2001a; Fernandez et al., 2000), Bacillus 
subtilis (Au et al., 2005; Goranov et al., 2006), Pseudomonas aeruginosa (Cirz et al., 2006) and 
Staphylococcus aureus (Cirz et al., 2007), showed that the regulon is made up of at least 15 
genes, including recA, lexA and at least one error-prone DNA polymerase (Butala et al., 2009). 
About 63 genes of the regulon are controlled by the lexA-like gene dinR (damage inducible 
gene) (Raymond and Guillen, 1991) in Bacillus subtilis (Au et al., 2005) and remarkably only 
seven of them are homologous in E. coli. This illustrates the diversity of the SOS network.  
LexA participates as a transcriptional repressor in all these cases, blocking the access of 
RNA polymerase to the promoters. However, in few cases, LexA plays an opposite role. The 
LexA paralog in Rhodobacter sphaeroides (Tapias et al., 2002) and the Synechocystic sp. 
Cyanobacterium (Gutekunst et al., 2005) activates transcription. Interestingly, in several 
bacterial species of Pseudomonas and Xanthomonas, there are two copies of LexA, LexA1 and 
LexA2. Thus the lexA gene is duplicated in these cases (Abella et al., 2007). LexA1 takes part 
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in the conventional SOS response and LexA2 binds to a different SOS box of DNA and 
regulates the expression of two error-prone DNA polymerases (Butala et al., 2009).   
 
2.3 Overall structure of LexA 
E. coli LexA is a 202 amino acid protein encoded by the lexA gene. It folds into two 
structurally defined domains: a carboxy-terminal domain (CTD) and an amino-terminal domain 
(NTD), linked by a flexible hinge region (Figure 2.2A) (Luo et al., 2001; Oertel-Burchheit et 
al., 1993). The CTD helps the protein to dimerize (Luo et al., 2001; Schnarr et al., 1988) and 
the NTD helps the LexA protein to bind to DNA with its helix-turn-helix motif.  
The crystal structure of the full length LexA mutant (PDB ID: 1jhh and 1jhf, Luo et al., 
2001) and the three dimensional structure of the LexA-NTD by NMR spectroscopy were 
reported (PDB ID: 1lea) (Fogh et al., 1994). The crystal structure of E. coli LexA is presented 
in the Figure 2.2A. LexA is a member of the ‘winged helix’ family of DNA-binding proteins 
(Brennan, 1993; Dumoulin et al., 1996; Holm et al., 1994; Madan and Teichmann, 2003). The 
DNA-binding domain, the NTD, is composed of three α-helices and two β-sheets. Residues 6-
21 (a1), 28-35 (a2) and 41-52 (a3) produce three α-helices and two anti-parallel β sheets (b1 
and b2) follow the helices (Figure 2.2A). a2 and a3 form the helix-turn-helix (winged helix) 
DNA-binding motif (Fogh et al., 1994). The NTD is composed of the first 69 residues followed 
by a hinge region (domain linker) to connect it to the CTD. The two domains make contact 
through 470 Å2 of buried surface in between them (Luo et al., 2001). 
The domain linker or hinge is extended from residues Gln70 to Glu74 (light green, 
Figure 2.2B), which is a hydrophilic region and not a simple linker. Its sequence showed the 
importance of the formation of specific LexA-DNA contacts (Butala et al., 2007). Different 
crystal structures of the LexA mutants (S119A and G85D, PDB ID: 1jhh and 1jhf) showed that 
this connector region is solvent-exposed (Luo et al., 2001). These regions of each subunit 
maintain the positions of the two NTDs in a LexA dimer and do not allow any additional base 
pairs at an operator between the two DNA-binding motifs (Oertel-Burchheit et al., 1993). 
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Figure 2.2 Crystal structure and a cartoon diagram of the domains of E. coli LexA. 
A) Crystal structure of E. coli LexA dimer (Luo et al., 2001). Two different subunits are shown 
in different colors (top: dark green, bottom: blue). One of the N-terminal domains (NTD) was 
disordered during crystal packing and was omitted from the figure (bottom monomer). NTD is 
composed of three α helices (a1-a3) and two β strands (b1 and b2). C-terminal domain (CTD) is 
entirely composed of β strands (b3-b11). The catalytic core is composed of b5-b11. The 
cleavage site region (CSR) [composed of b3 and b4 with intervening loop (red)], linkers 
(purple) [between the b4 (CSR) and b5 (catalytic core)], cleavage site residues (light green) and 
catalytic residues (yellow) are shown in different colors. The hinge region is shown by an arrow 
in the top monomer. Two CTDs are interacting in part with the two anti-parallel β strands 
(b11). The figure was prepared from LexA S119A mutant (PDB ID: 1jhh) and the S119 residue 
was reconstructed by the authors (Luo et al., 2001) from the G85D mutant (PDB ID: 1jhf) B) 
Cartoon diagram showing the domains of a LexA monomer. The NTD, hinge and CTD are 
shown in dark green, light green and cyan, respectively. Residue numbers showing domain 
ranges are given on top of each domain and hinge, and the font colors are consistent with the 
domain colors. Reprinted with the permission from Elsevier (Cell) (Luo et al., 2001). 
B 
NTD  Hinge  CTD 
1  69 70  74 75  202 
A 
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The C-terminal domain (CTD) of LexA is entirely composed of β strands (b3-b11, 
Figure 2.2A) and contains the determinants of oligomerization and self-cleavage (Luo et al., 
2001). b5-b11 composed the catalytic core which contains the Ser119 and Lys156 (Ser/Lys 
dyad), the key catalytic residues in LexA (yellow, Figure 2.2A). They act as the serine 
nucleophile and general base, respectively (Slilaty and Little, 1987). The bond between residues 
Ala84 and Gly85 is cleaved by catalysis of the Ser/Lys dyad. Ala84 and Gly85 are located in a 
loop in the CTD, called the cleavage site region (CSR), in between the b3 and b4. The CSR is 
connected to the catalytic core (b5-b11) with a linker which helps the movement of CSR to 
switch between two different conformations (purple, Figure 2.2A; Figure 2.3). The loop is away 
from the catalytic site in one conformation (Figure 2.3A-B), whereas it is buried between the 
Ser/Lys dyad in another conformation (Figure 2.3C-D) (Luo et al., 2001). The LexA structure 
switches between these two conformations, called cleavable (C) and non-cleavable (NC) 
conformations. The CSR sweeps ~20 Å from the NC form to the C form to present the cleavage 
site to the catalytic site in.  
 
2.4 The homologues of LexA 
Several proteins have been reported as homologues of LexA. These are called LexA 
superfamily proteins. The lytic repressors from the lambdoid phages and the UmuD protein 
from bacteria are some well known homologues of LexA. UmuD is expressed from the 
derepression of umuCD operon upon LexA cleavage during the SOS response. E. coli UmuD is 
a mutagenic factor which is involved in an error-prone DNA synthesis machinery to bypass the 
DNA lesions (Rajagopalan et al., 1992; Shinagawa et al., 1988). The catalytic Ser/Lys dyad 
found in LexA and other repressors is conserved in the UmuD protein. However, the cleavage 
site in UmuD (Cys-Gly) is different from that of LexA (Ala-Gly). UmuD has a Cys residue 
instead of Ala. In spite of the difference, it is not surprising that UmuD can also be cleaved by 
the interaction with the activated RecA protein (auto-cleavage) and can follow the same 
catalytic mechanism as the LexA cleavage (Shinagawa et al., 1988). UmuD cleavage involves 
the removal of first 24 residues from the N-terminal and produces a truncated protein called 
UmuD′. UmuD′ generates the functional DNA polymerase V (UmuD′2C-RecA-ATP) along 
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with UmuC and RecA, which helps to fill up the single stranded gaps in the DNA lesion sites 
(Jiang et al., 2009; Reuven et al., 1999; Tang et al., 1999).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Two different conformations of LexA CTD. 
Left side figures are space filling and right side figures are ribbon representations of the LexA 
CTD. A and B are in non-cleavable conformations where the cleavage site, Ala84-Gly85, (red 
polypeptide chain) is ~20 Å away from the catalytic site, Ser119/Lys156. While in the 
cleavable conformations (C and D), the cleavage site is completely buried in between the 
catalytic site. These figures were prepared from LexA S119A mutant (PDB ID: 1jhh) and the 
S119 residue was reconstructed by the authors (Luo et al., 2001) from the G85D mutant (PDB 
ID: 1jhf). Reprinted with the permission from Elsevier (Cell) (Luo et al., 2001). 
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During the lysogenic phase of the lambdoid phage infection, the phage DNA is 
integrated into the host chromosome and the expression of the phage proteins is repressed by 
the phage repressors. Escape of the prophage from the host (lytic phase) requires the 
inactivation of the repressor protein. In order to permanently inactivate the repressor, prophage 
exploits the part of the SOS pathway of the host. This includes the interaction of the activated 
RecA filament which stimulates the intrinsic autoproteolytic activity of the phage’s repressor 
protein. Cl repressors from different phages (λ, φ80, p22, 434 etc.) have been shown to possess 
this kind mechanism (Eguchi et al., 1988; Roberts et al., 1978; Sauer et al., 1982).  
Amino acid sequence alignment of the LexA repressors, SOS response proteins and cl 
phages repressors is presented in the Figure 2.4. The cleavage site (Ala/Cys-Gly) and catalytic 
residues (Ser/Lys) are conserved in all of the LexA superfamily proteins. 
 
  
 
 
 
 
 
 
Figure 2.4 Sequence alignment of the CTDs of proteins from LexA superfamily. 
Sequence of the C-terminal domains of LexA repressors (1st and 2nd), SOS response proteins 
(3rd and 4th) and phage repressors (5th and 6th) are aligned. The labels (left side) give the name 
of the proteins, name of the organisms in parenthesis and the starting sequence number. β-
strands, residue sequences and numbering of LexA repressor, UmuD′ and λ Cl repressors are 
colored in red, blue and green respectively. The secondary structure diagrams of the three 
repressors are shown on top of the alignment and the colors are consistent with the residue 
colors. The conserved residues including the cleavage sites (A/C-G), and the catalytic residues 
Ser and Lys are marked with blue colors (fonts and triangles). Reprinted with the permission 
from Elsevier (Cell) (Luo et al., 2001). 
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2.5 Dimerization of LexA: the functional repressor formation 
The number of LexA molecules in non-induced E. coli is approximately 1300, of which 
20% are free and non-DNA-bound (Sassanfar and Roberts, 1990). The level of LexA falls 10-
fold upon induction of the SOS response and when RecA becomes activated (Dri and Moreau, 
1994; Sessanfar and Roberts, 1990). There is a tryptophan residue at position 201 of LexA and 
it is buried within the dimer interface. Because of this, pressure-dependent changes in the 
intrinsic tryptophan of LexA can be measured. The results from these experiments revealed that 
the LexA proteins are predominantly dimeric in solution and the level of monomeric LexA is 
minute (Mohana-Borges et al., 2000). Therefore, it can be understood that LexA interacts or 
recognizes its targets as a dimer. The target is the operator DNA sequence, which is composed 
of two symmetrically inverted binding elements. Each of those elements binds to a single 
subunit of LexA (Thliveris et al., 1991). This binding significantly increases the LexA dimer 
stability by about 1000-fold (Mohana-Borges et al., 2000). Dimerization of LexA maximizes 
SOS gene repression and brings about a high degree of cooperativity.  
The determinants for the dimerization of LexA are found entirely in the CTD (Luo et 
al., 2001). The dimerization interface is composed of residues from the two loops (Gln99 to 
Asp110 and Ser116 to Gly128) and a portion of the β-11 strand of the CTD (Figure 2.2A).  
Residues 186 to 198 compose the two antiparallel β-11 strands of the CTD. It was observed 
from the crystal structure of LexA (PDB ID: 1jhh) that residues 195 to 198 (Val195-Ile196-
Arg197-Gln198) of the β-11 strands participate in the interaction at the dimer interface. A total 
of approximately 1380 Å2 of area is buried at the interface (Luo et al., 2001). The mechanism 
of LexA-DNA binding and the LexA dimerization were presumed to be as follows: two LexA 
monomers first separately sit on an operator with the individual NTD and then the two CTDs 
come close and interact with each other to form a dimer (Schnarr et al., 1988; Schnarr et al., 
1985). This results in DNA bending as well. From the in vitro studies, the formation and 
dissociation of LexA dimers were observed as a slow process (Giese et al., 2008) that takes 
minutes rather than seconds. However, when LexA is inactivated by self-cleavage, the cleavage 
fragments dissociate faster from the heterodimer than the intact LexA dimers. 
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2.6 LexA operator and the specific DNA binding 
LexA can access binding sequences in any part of the bacterial genome (Wade et al., 
2005) in spite of chromosomal folding into the nucleoid (Dame, 2005). The consensus DNA 
sequence of LexA binding is called ‘the SOS box’, which is located in the operator region of 
the SOS genes. This box is found in most of the SOS genes. The DNA sequence in the SOS box 
is usually taCTGT(at)4ACAGta and displays an imperfect palindromic structure. (Lewes et al., 
1994). E. coli has this type of consensus sequence [CTGT(N)4ACAG] (Walker, 1984). This 
consensus sequence is conserved in many other Gram-negative bacteria, whereas the consensus 
sequence is GAAC(N)4GTTC in Gram-positive bacteria (Erill et al., 2007) and it is actually 
termed a Cheo box (Cheo et al., 1991). There are 30 LexA boxes that have been found in E. 
coli; however, LexA can bind to another 19 targets that lack the conventional site (Wade et al., 
2005). The LexA repressor binds selectively to the CTGT sequence, particularly to the central 
TG bases.  
Specific binding of the protein to the DNA targets requires energetically favorable 
interactions between the residues in the binding site and specific base pairs. This may be 
coupled with conformational changes in both the protein and the DNA (Lim et al., 2002; Tiebel 
et al., 1999; Wisedchaisri et al., 2004; Zhang et al., 1987). Many transcriptional regulators 
switch between the DNA binding and non-binding conformations. The crystal or NMR 
structure of the LexA-DNA complex has not yet been determined (Dumoulin, 1996). Therefore, 
the specific contacts of E. coli LexA NTD with DNA have been studied by several biochemical 
and biophysical methods (Dumoulin et al., 1993; Hurstel et al., 1988; Lloubes et al., 1991; 
Oertel et al., 1992; Oertel et al., 1990; Ottleben et al., 1991; Thliveris et al., 1991).  
The binding of a half site of the LexA operator, that is with just one subunit of LexA, 
has 1000-fold lower affinity from the dimer (Kim and Little, 1992). Therefore, the interaction 
between the two subunits of LexA with a dyad symmetry is required for the tight binding to the 
consensus sequence. This stabilizes the interaction with both halves of the DNA (Kühner et al., 
2004; Mohana-Borges et al., 2000). 
It was revealed by a model that the free conformation of LexA found in the crystal 
structure (Luo et al., 2001) would not allow the NTD of both subunits to dock with both halves 
of a symmetric operator (Chattopadhyaya and Pal, 2004). A study using molecular dynamic 
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simulations of the LexA dimer binding to the operator DNA sequence created by CHARMM 
biomolecular simulation program (Brooks et al., 2004) showed that a reorientation of the NTD 
of LexA with respect to the CTD is essential for the specific operator binding (Butala et al., 
2009). This was also confirmed by in vitro experiments exploiting cysteine crosslinking (Butala 
et al., 2007). Another study with a homolog from Bacillus subtilis indicated that either 
substantial DNA bending or a conformational change in LexA must occur for specific operator 
binding (Stayrook et al., 2008). 
    
2.7 Overview of RecA protein and its functions 
Bacterial RecA protein belongs to the universal recombinase superfamily found in 
almost every form of life. It is part of the group of ATPase proteins homologous to archaeal 
RadA (Sandler et al., 1996) and eukaryal Rad51 (Shinohara et al., 1992) and DMC1 (Bishop et 
al., 1992). The existence of RecA was first reported by Clark and Margulies in 1965 while 
describing a class of mutations in E. coli that completely lacked genetic recombination during 
bacterial conjugation (Clark and Margulies, 1965). As a result of their experiment and a series 
of other experiments over the last 40 years on bacterial, archaeal and eukaryotic recombinases, 
the RecA family was found to be the principal catalyst of homologous recombination (Radding, 
1981; Seitz et al., 1998; Shinohara et al., 1992). Homologous recombination is the complete 
exchange of strands between two homologous DNA molecules. Recently, key steps in the 
mechanism of homologous DNA recombination and the functional details of the RecA in the 
catalysis were elucidated (Chen et al., 2008). Additionally, experiments revealing a relationship 
between the recombination proficiency and UV resistance of various mutants showed that there 
is a functional relationship between homologous recombination and DNA damage repair (Clark 
and Margulies, 1965; Clark and Volkert. 1978; Howard and Theriot, 1966; Wang and Smith, 
1983). Further studies demonstrated that homologous recombination is crucially important and 
related to repairing double-stranded DNA breaks and restarting stalled replication forks (Cox, 
1998; Cox et al., 2000; Courcelle et al., 2001b; Kowalczykowski, 2000; Lusetti and Cox, 
2002). This is also related to SOS mutagenesis. The DNA damage repair mechanism is induced 
by the co-protease activity of RecA during the SOS response. A low fidelity DNA polymerase 
in bacteria, DNA polymerase V (Reuven et al., 1999; Tang et al., 1999), forms during the SOS 
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response to repair the double-stranded DNA break. This process, called translesion synthesis, is 
an error-prone DNA synthesis mechanism that produces random mutations (Kato and Shinoura, 
1977; Steinborn, 1978). A very recent study revealed that RecA is a structural component of the 
active form of DNA polymerase V, which is a complex of UmuD′2C-RecA-ATP (Jiang et al., 
2009). Therefore, RecA has been found to have at least three confirmed functions: homologous 
recombination, co-protease activity and translesion synthesis.   
 
2.7.1 Active and inactive RecA: two structurally different conformations 
RecA is a ~350 residue bacterial protein. The E. coli RecA consists of a 30-residue-long 
amino-terminal α-β motif, an α/β ATPase core of 240 residues and a 64-residue-long globular 
carboxy-terminal-domain (CTD) (Figure 2.5) (Story et al., 1992). RecA binds to ssDNA in an 
ATP-dependent manner using the ATPase core and forms a helical nucleoprotein filament. The 
RecA filament exists in two different conformations (DiCapua et al., 1990; Morimatsu et al., 
2002; Vanlook et al., 2003b). The inactive conformation forms the self-polymeric filament of 
RecA protomers in the absence of DNA molecules (Figure 2.5A). It is a wide and compressed 
helical filament with an average helical pitch of ~83 Å (DiCapua et al., 1990; Flory et al., 1984; 
Vanlook et al., 2003b; Yu et al., 2001). Another distinct conformation is the active RecA which 
forms an elongated filament in the presence of DNA and ATP (Figure 2.5B). The active RecA 
filament is a narrow and extended filament having a pitch value ranging from 91 to 97 Å 
(DiCapua et al., 1990; Flory et al., 1984; Morimatsu et al., 2000; VanLoock et al., 2003b; Yu et 
al., 2001).  These two distinct conformations can also be found in archaeal RadA (Wu et al., 
2004) and eukaryotic Rad51 proteins (Conway et al., 2004; Galkin et al., 2006; Hilario et al., 
2009). The two different conformations of RecA are shown in the Figure 2.5. The inactive 
crystal structure shows that the regions that are involved in the DNA binding, called L1 and L2 
loops, are disordered and could not be seen (yellow arrows, Figure 2.5A) (Story et al., 1992); 
whereas, the loop regions became ordered in the active crystal structure (yellow arrows, Figure 
2.5B) (Chen et al., 2008).  
Active filament formation is highly cooperative and its nucleation requires the assembly 
of five to six RecA protomers (Galleto et al., 2006; Joo et al., 2006; Kelley et al., 2001). 
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Structural details of the active RecA filament of E. coli have been reported (Figure 2.6) (Chen 
et al., 2008).  
 
 
 
 
 
 
 
 
 
Figure 2.5 Crystal structure of inactive and active E. coli RecA monomer. 
The inactive (A) and active (B) crystal structures of RecA monomer (PDB ID: 2reb, inactive 
monomer, Story et al., 1992 and PDB ID: 3cmu, active monomer, Chen et al., 2008). The 
structure of a RecA monomer has a large core domain (grey) and two smaller domains at the N- 
and C-termini (purple and green, respectively). The L1 and L2 loops are indicated with yellow 
arrows. These L1 and L2 loops were disordered (red dotted lines) in the inactive structure (A) 
and became highly ordered in the active structure (B). Figures were created with PyMOL. 
 
According to the study by Chen et al. (2008), the nucleoprotein filament has a helical 
repeat average of 6.16 RecA per turn and a pitch of 93.96 Å. This description resembles the 
other predicted active filament structures (Bell, 2005; Bianco et al., 2005; Cox, 2007c; Flory et 
al., 1984; McGrew and Knight, 2003; Stasiak and DiCapua, 1982; Yu et al., 2001). The 
ssDNA-bound RecA filament is termed the presynaptic complex. The active RecA crystal 
structure (Chen et al., 2008) showed that ssDNA was located in close proximity and also 
helically wrapped around the axis of the nucleoprotein filament. It is in B-DNA-like 
conformation, but underwound with average helical parameters of 18.5 nucleotides per turn and 
5.08 Å rise per base pair (bp). Exactly three nucleotides of the ssDNA are bound to a single 
RecA protomer. ssDNA made contact with the RecA protein through the L1 and L2 regions and 
L1  
L2 
N
C
B 
L1  
L2 
N 
C 
A 
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a portion of two α helices of the N-terminal (Chen et al., 2008). The L1 and L2 contact portions 
in the helix were followed by the N-terminal region whereas the L1 and L2 portions of RecA 
were found disordered in the inactive filament (Bell, 2005), whereas in the DNA-bound 
structure, they became highly ordered. The ATP binding pocket lies between the two ATPase 
cores of two RecA protomers in the presynaptic filament, which forms a completely buried 
environment.  
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Crystal structure of E. coli RecA nucleoprotein filament (presynaptic complex). 
Structure of the RecA6-(dT)18 complex (PDB ID: 3cmu, Chen et al., 2008). The six RecA 
protomers are numbered from the N-terminal RecA subunit to onwards. They (RecA1-RecA6) 
are colored dark red, golden, cyan, purple, yellow and green, respectively. The DNA backbone 
is marked by a red coil. Only 15 of the 18 nucleotides were found ordered (red) in the crystal 
strucuture of six protomers. Figure was created with PyMOL.  
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2.8 Mechanism of the RecA-mediated cleavage of LexA 
LexA is resistant to intracellular degradation under physiological conditions (Neher et 
al., 2003), but cleavage is triggered by the interaction with activated RecA (Little, 1991). 
However, LexA slowly undergoes auto-cleavage in solution (Little, 1984). Self-cleavage can 
occur in a RecA-dependent manner in vitro at alkaline pH (Little, 1984). Active RecA 
stimulates LexA to auto-digest at a faster rate (Little, 1991). Two residues of the CTD of LexA, 
Ser119 and Lys156, act as catalytic residues during the cleavage (Ser/Lys dyad). This dyad 
cleaves the peptide bond between two other residues (Ala84 and Gly85) in the same domain. 
LexAs from different bacterial species and its homologs (UmuD and λ repressor, for example) 
consistently contain these conserved residues (Figure 2.4) and therefore, are thought to possess 
the same type of cleavage mechanism.  
LexA remains predominantly in a non-cleavable conformation in the absence of active 
RecA, and the ε-amino group of Lys156 of LexA is favorably protonated and exposed to the 
aqueous environment. At this stage, Lys156 cannot act as a general base in activating the 
catalytic Ser119 residue. Thus, the self-cleavage of LexA is kept in check. RecA’s co-protease 
activity facilitates the LexA self-cleavage by providing a hydrophobic pocket (Lin and Little, 
1989), which offsets the energetic cost in the burial and neutralization of the ε-amino group of 
Lys156 in LexA (Figure 2.7) (Luo et al., 2001). The cleavable conformation of LexA, in which 
Lys156 is buried and deprotonated, increases its rate of self-cleavage by ~104-fold at neutral pH 
as explained by the conformation-equilibrium model (Roland et al., 1992). During auto-
cleavage, Lys156 removes a proton from Ser119 and therefore makes it nucleophilic, which in 
turn allows it to attack the Ala84-Gly85 peptide bond (Figure 2.7) (Slilaty et al., 1992). The 
Ser/Lys dyad model is supported by mutational studies (Lin and Little, 1989; Lin and Little, 
1988; Slilaty and Little, 1987). Replacing Ser119 or Lys156 with alanine (S119A or K156A 
mutations) produces non-cleavable LexA. It has been proposed that LexA can exist in two 
distinct conformations, cleavable and non-cleavable. In the non-cleavable form, the Ala84-
Gly85 polypeptide chain stays ~20 Å away from the Ser/Lys dyad (Figure 2.3). However, it 
bends significantly in the cleavable conformation, presenting the cleavage site to the catalytic 
Ser119 and burying Lys156 (Luo et al., 2001). The buried Lys156 is exposed to an 
environment where a positive charge is not stable (Luo et al., 2001).  
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Figure 2.7 Cartoon drawing of the LexA self-cleavage catalysis mechanism. 
Uncharged Lys156 pulls a proton from the hydroxyl group of Ser119 and enhance the 
nucleophilicity. The nucleophilic oxygen then attacks the carbonyl carbon of Ala84 and forms a 
transient bond between Ser119 and Ala84. In the next step, nitrogen from the α-amino group of 
Gly85 absorbs one proton from the ε-amino group of Lys156 and the peptide bond between 
Ala84-Gly85 is cleaved. The hydrolysis of the transient bond between Ala84 and Ser119 takes 
place in the next step by one incoming water molecule, and at the end of the reaction one N-
terminal and one C-terminal fragments of LexA are produced. The red arrows show the 
direction of electron transfer. (This figure was modified from Slilaty and Little, 1987.) 
 
H2O
N‐terminal + C‐terminal fragments of 
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A tetrahedral intermediate is formed during the catalysis process of classic Ser-His-Asp 
proteases like chymotrypsin. The intermediate is favourably stabilized by a structural feature 
known as the ‘oxyanion hole’. Luo et al. (2001) showed that, the Ser-Lys proteases like LexA 
superfamily also possess the same mechanism. Figure 2.8 shows the catalytic site of the 
cleavable form of LexA. Ala84 O, lies within hydrogen-bond distance of two adjacent main 
chain amide nitrogens of Ser119 (2.8 Å) and Met118 (3.2 Å), and this location is the oxyanion 
hole of LexA. The conformation of oxyanion hole is stabilized by hydrogen bonding to the 
adjacent glycine main chain atoms (Gly117) to a solvent molecule and to a side chain of 
Asp127. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 Stabilization of the catalytic site region peptide complex in the oxyanion hole of 
LexA.  
A) A ball and stick model of the catalytic site of the cleavable form of the CTD of LexA. The 
carbon chain of the catalytic site region and the catalytic core are colored in green and grey, 
respectively. Oxygen and nitrogen are colored in red and blue regardless of their location. 
Hydrogen bonds are shown as yellow dashed lines. B) The catalytic site with electrostatic 
surface. The electropositive surface is colored in blue and electronegative surface is colored in 
red. Th e position of the oxyanion hole is pointed. Reprinted with the permission from Elsevier 
(Cell) (Luo et al., 2001). 
 
Deprotonation of Lys156 is required for cleavage (Lin and Little, 1989) since auto-
cleavage is efficient only at a high pH (Little, 1984). RecA does not participate directly in the 
A B 
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chemistry of cleavage reaction, and in particular, does not appear to affect the pKa of Lys156 in 
the cleavable conformation. In fact, the energetic cost of burying the lysine terminal amino 
group may help to keep the auto-cleavage reaction in check. However, the crystal structures of 
the LexA C-terminal domain in the non-cleavable and cleavable forms are very similar, except 
for the movement of the cleavage site region (Figure 2.3). Luo et al. suggested that this argues 
against an allosteric effect by RecA (Luo et al., 2001). Instead, the authors postulated that RecA 
binds preferentially to the cleavable conformation of LexA, stabilizing this form and promoting 
cleavage (Luo et al., 2001; Ronald et al., 1992). However, Ronald et al. (1992) showed that less 
than 1 in 4000 LexA molecules are in the cleavable conformation used for RecA-dependent 
cleavage at pH 7.4 (Ronald et al., 1992). Therefore, it is a little impractical if RecA only binds 
with the cleavable conformation of LexA and thus the concentration of LexA drops tenfold in 
the cell. However, Kim et al. (2008) recently postulated that RecA can bind to the non-
cleavable form of LexA as well and therefore acts, at least in part, through an allosteric 
mechanism during cleavage (Giese et al., 2008), i.e., converting LexA from the non-cleavable 
conformation to the cleavable conformation. Thus, the interaction of LexA with RecA-ssDNA 
shifts the equilibrium of the LexA concentration towards the cleavable conformation. 
 
2.9 Overview of the structural interactions between LexA and RecA  
The active RecA filament mediates self-cleavage of the LexA repressor. Though the 
role of RecA in LexA catalysis is indirect, LexA and RecA have to physically interact. The 
three dimensional structure of the LexA and RecA complex is not available to help understand 
precisely the interactions and the mechanism of LexA catalysis. However, several attempts had 
been undertaken to reveal the binding sites of LexA on the RecA protein. The apparent Km of 
LexA binding to RecA nucleoprotein filament has been estimated to be approximately 0.5 μM 
(Lin, 1988). However, a non-cleavable LexA mutant, such as K156A, was found to bind 
activated RecA more tightly than the wild-type (Slilaty and Little, 1987). This mutant has been 
used in several experiments to study the interaction between RecA and LexA. 
Activated RecA forms an extended helical filament with ssDNA that has a higher 
helical pitch than the inactive filament. Interestingly, RecA ATPase activity can be activated by 
high salt in the absence of DNA and it also forms an extended helical filament (95 Å pitch) 
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(Pugh and Cox, 1988). This salt-activated RecA shows co-protease activity as well (Dicapua et 
al., 1990). Therefore, it is obvious that the extended helical filament of RecA is required for the 
cleavage of LexA. The simple explanation for this may be because LexA cannot fit into the 
compressed filament groove found in the inactive RecA filament. Attempts to fit the LexA 
difference density into inactive RecA filament reconstruction (Yu and Egelman, 1992) or into 
the inactive filament from the RecA crystal structure (Story et al., 1992) showed a huge 
overlapping density region (Yu and Egelman, 1993). Therefore, it is suggested that while RecA 
ATPase activity requires a highly specific conformation at the active site of catalysis, the 
catalysis of LexA cleavage and other repressors may be much less specific at the active site and 
depend upon a more general LexA orientation within the RecA groove or binding sites (Yu and 
Egelman, 1993). 
Story et al. (1992) suggested that the binding sites of LexA and other repressors are in 
the “notch” between lobes of the adjacent RecA subunits in the filament. Residues 329 to 354 
were not seen in the inactive crystal structure presumably due to a high degree of disorder 
(Story et al., 1992). These are the C-terminal residues of the E. coli RecA protein. Residues 229 
and 243 in the ‘notch’ region of RecA have been proposed to be involved in LexA binding 
(Story et al., 1992). By performing mutational studies, the residues located at this site were 
found to differentially affect RecA-mediated cleavage of the LexA repressor or its homologs in 
vivo. For example, the R243L mutation prevents cleavage of the φ80 repressor and UmuD 
protein (Dutreix et al., 1989), and the G229S mutation prevents φ80 repressor cleavage (Ogawa 
and Ogawa, 1986). These residues (Gly229 and Arg243) are located at the inner surface of the 
pendulous lobe of the activated RecA and protrude into the deep helical groove. However, 
based on an electron microscopy (EM) study on the RecA/LexA complex, no density from 
LexA was found in the notch itself (Yu and Egelman, 1993).  
It had been found that high concentration of ssDNA (Rehrauer et al., 1996) and dsDNA 
(Takahashi and Schnarr, 1989) can completely inhibit the RecA-mediated cleavage of LexA 
(DiCapua et al., 1992). Arg243 was reported to be at the site for secondary DNA binding to 
RecA (Mazin and Kowalczykowski, 1998). It has also been suggested that this site is an 
interaction site of dsDNA that helps releasing the complementary strands from the DNA-RecA 
filament complex during homologous recombination (Chen et al., 2008). A second LexA 
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binding site on RecA is located on a loop, which is called L1 (Story et al. 1992) and contains 
residues 156 and 165 (Yu and Egelman, 1993). This region was also disordered in the inactive 
crystal structure (Figure 2.5A) (Story et al., 1992), but became highly ordered in the active 
structure in the presence of DNA (Figure 2.5B) (Chen et al., 2008). In fact, the L1 loop and the 
C-terminal lobe (residues 268 to 330) have been implicated in dsDNA binding and are also in 
the binding vicinity of the LexA repressor. This observation is in agreement with the statement 
about the competitive nature of ssDNA/dsDNA and LexA for binding sites on the RecA 
filament. This can also explain why non-cleavable LexA (S119A mutant) acts as a competitive 
inhibitor of the DNA strand exchange activity of RecA (Harmon et al., 1996). 
The iterative helical real space reconstruction (IHRSR) has been applied using electron 
microscopy (EM) (Egelman and Stasiak, 1993) and crystal images (Story et al., 1992) to 
compare the RecA-DNA-LexA complex and the RecA filaments (VanLoock et al., 2003b). It 
was known and mentioned earlier that the average helical pitch of an active RecA filament is 
~94 Å (Chen et al., 2008; DiCapua et al., 1990; Flory et al., 1984; Morimatsu et al., 2000; 
VanLoock et al., 2003b; Yu et al., 2001), while it is ~ 82 Å in the inactive filament (DiCapua et 
al., 1990; Flory et al., 1984; VanLoock et al., 2003b; Yu et al., 2001). Though the main 
difference between the active and inactive RecA filament is the helical pitch, it was found from 
the filament reconstruction model that the pitch of the RecA-DNA-LexA complex was 84.7 Å, 
close to the 82.07 Å found in the inactive crystal structure. 
However, it can be seen that though the helical pitch is similar, the two filaments are 
quite different at low resolution (Figure 2.9A-B) (VanLoock et al., 2003b). The  modeled 
activated RecA filament model (VanLoock et al., 2003a) was docked onto the RecA-DNA-
LexA complex; it was shown that subtracting the density of the RecA model from that of the 
actual RecA-LexA reconstruction reveals a large mass of density near the axis of the RecA 
filament (yellow mesh, Figure 2.9C-D). In addition to this, a small mass of additional density is 
found ~6 Å from residue 328, the last C-terminal residue of RecA resolved in the inactive 
crystal structure (Figure 2.10A). This density was not found in low resolution EM 
reconstructions (VanLoock et al., 2003b). 
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Figure 2.9 EM reconstruction of the RecA-ATP-DNA-LexA filament complex. 
A is the low resolution surface model that was generated from the low resolution density of the 
inactive crystal structure of RecA with the difference density due to LexA, while B is the actual 
low resolution surface of the inactive crystal filament. C is a model for the LexA-bound RecA 
active filament (VanLoock et al, 2003a) and D is the LexA-bound RecA crystal structure of the 
inactive filament (Story et al., 1992). The orange arrow in D shows the protruded region of 
RecA from the density map, which indicates that the inactive crystal structure of RecA fits 
poorly with the reconstructed LexA-RecA filament. In both C and D, the difference density 
obtained by subtracting RecA from the LexA–RecA complex is shown with a yellow mesh. 
Reprinted with the permission from Elsevier (Journal of Molecular Biology) (VanLoock et al., 
2003a). 
A B 
C D 
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The large density due to LexA was disconnected from the additional density found; 
therefore, it may not be due to LexA. A possible explanation for this additional density is that 
LexA binding near the filament axis may induce an allosteric stabilization of this region of 
RecA. Several other papers suggested that these C-terminal residues also act as an allosteric 
regulatory switch (Eggler et al., 2003; Lusetti et al., 2003a; Lusetti et al., 2003b). Consistent 
with these findings, it was found that, cleaving the residues from this region results in the 
induction of an allosteric conformational change involving the nucleotide-binding core (Yu and 
Egelman, 2001). 
 
 
 
 
 
 
 
 
 
 
Figure 2.10 A single subunit from the fittings using both the RecA model (A, red) and the 
RecA crystal filament (B, green) along with the difference density (yellow). 
RecA residues implicated in LexA binding are shown as spheres (154–156, purple; 67, 229 and 
243, blue). Residues 67, 229 and 243 are immediately adjacent to the mass due to LexA in the 
model (black arrows in e and f), but are displaced from the LexA density when the inactive 
crystal filament was used. The distance between the most C-terminal RecA residue (Leu328) 
observed in the inactive crystal structure (Story et al., 1992) and a mass that is likely due to 
residues 329–354 (not seen in the inactive crystal structure) is indicated with a broken line. 
Reprinted with the permission from Elsevier (Journal of Molecular Biology) (VanLoock et al., 
2003a). 
 
Several residues in a RecA subunit were previously reported to make contact with 
LexA: 67 (Konola et al., 1998); 154-156 (Nastri et al., 1997); 229 (Ogawa and Ogawa, 1986); 
A B 
 28 
 
and 243 (Dutreix et al., 1989). The larger difference density (yellow mesh, Figure 2.10C), 
presumably due to the presence of LexA close to the axis of the nucleofilament in the EM 
reconstruction model, can be compared to these contact regions (Figure 2.10). These residues in 
RecA are in close proximity to the LexA density (Figure 2.10A), whereas they are not in direct 
contact with the LexA mass in the inactive RecA crystal structure (Figure 2.10B). 
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Chapter Three: Objectives 
The overall objective of this study was to produce a stable complex of two proteins from 
Escherichia coli, RecA and LexA, and to co-crystallize them. This goal can ultimately help 
solve the three-dimensional crystal structure of the RecA and LexA complex.  
 
To achieve this goal, the following experiments were performed: 
 
1. Producing non-cleavable LexA proteins with dimer interface mutants in order to purify 
a predominantly monomeric LexA in solution. 
2. Screening out the predominantly monomeric LexA from the mutants produced. Two 
experiments were performed to accomplish this goal: 
a. Size exclusion chromatography and  
b. Dynamic light scattering (DLS). 
3. Determining the binding strength of the LexA dimer interface mutants with RecA. For 
this, the co-protease inhibition assay was performed. 
4. Attempting to co-crystallize the monomeric dimer-interface-mutants of LexA and 
RecA. Objective 4 was a part of the future studies. If objective 4 gave positive results, 
the current study would continue to research for PhD degree. 
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Chapter Four: Materials and Methods 
4.1 Materials 
Table 4.1 Materials and equipments used for the experiments. 
Object Provider
Cells 
Rosetta (DE3) 
XL1-Blue  
 
Novagene 
Stratagene 
DNA 
pET28a-c(+) vector 
ssDNA (dT45, dT22, dT20, dT18) 
Primers 
 
Novagene 
Integrated DNA Technology 
Integrated DNA Technology 
Media 
Agar 
Bacto-Tryptone 
LB Miller broth 
Peptone 
Yeast Extract 
 
BD Biosciences 
BD Biosciences 
BioShop, BD Biosciences 
BD Biosciences 
BD Biosciences 
Cloning enzymes and buffers 
10X DNA ligase buffer 
10X Thermopol reaction buffer 
NdeI 
Pfu DNA polymerase 
T4 DNA ligase 
Taq DNA polymerase 
Thrombin 
XhoI 
 
MBI Fermentas 
New England Bio Labs 
New England Bio Labs 
MBI Fermentas 
MBI Fermentas 
New England Bio Labs 
Sigma 
MBI Fermentas 
Other materials 
AMPPCP 
AMPPNP 
ATP 
Agarose  
 
Sigma 
Sigma 
Sigma 
Invitrogen Life Technologies 
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Acetic acid (glacial) 
Acrylamide (electrophoresis grade) 
Ammonium persulfate 
Ammonium sulfate 
Ampicillin (sodium salt) 
Boric acid 
Bradford reagent 
Bromophenol blue 
Chloramphenicol 
Coomassie Brilliant Blue R-250 
dNTPs (dATP, dCTP, dTTP, dGTP) 
Ethidium bromide 
Ethanol (95%) 
EDTA (ethylenediaminetetraacetic acid) 
Glycerol 
Hydrochloric acid  
HEPES (N-2-hydroxyenthylpeperazine-N’-2-ethane-sulfonic acid) 
Imidazole 
IPTG (Isopropyl-thio-β-D-galactoside) 
Kanamycin sulphate 
Lysozyme 
Magnesium acetate 
Magnesium chloride (hexahydrate) 
Magnesium sulphate 
MES [2-(N-morpholino)-ethane sulfonic acid monohydrate] 
2-Mercaptoethanol 
Nickel sulfate (hexahydrate) 
Potassium chloride 
Sodium chloride 
SDS (sodium dodecyl sulfate) 
Sucrose 
Tricine 
EMD Chemicals Inc 
Sigma 
EMD Chemicals Inc 
EMD Chemicals Inc 
BioShop 
EM Science 
Bio-Rad 
Alfa Aesar 
BioShop 
AnaSpec 
Amersham Biosciences 
Sigma 
Commercial Alcohols Inc 
EMD Biosciences 
EMD Biosciences 
BDH Inc 
BioShop 
Avocado Research Chemicals Ltd 
EMD Chemicals Inc  
BioShop 
Sigma 
BioShop 
EMD Chemicals Inc 
EMD Chemicals Inc 
EMD Chemicals Inc 
BioShop 
EMD Chemicals Inc 
EMD Chemicals Inc 
EMD Chemicals Inc 
Calbiochem 
EMD Chemicals Inc 
BioShop 
 32 
 
Tris [Tris (hydroxymethyl) aminomethane]
Urea 
EMD Chemicals Inc 
EMD Chemicals Inc 
Equipment and other 
375 Hotplate/Stirrer 
ÄKTA Prime Protein Purification System 
Allegra X-22R Centrifuge 
Avanti J-25 Centrifuge 
Centrifuge 5415D 
CP 124S (balance) 
DynaPro MS800 
Electroporator 2510 
HiPrep 16/60 Sephacryl S-100 High resolution 
HiPrep 16/60 Sephacryl S-300 High resolution 
Incubator 
Innova 43 Incubator Shaker 
Mastercycler Gradient 
Mini Vortexer 
Orbit Environ Shaker 
QIAgen Miniprep Kit 
QIAgen Gel Extraction Kit 
Sonic dismembrator Model 500 
Symphony pH Meter 
Ultrospec 2100 pro 
UV illuminator 
 
VWR Scientific 
Amersham Biosciences 
Beckman Coulter 
Beckman Coulter 
Eppendorf 
Sartorius 
Protein Solutions 
Eppendorf 
Amersham Pharmacia Biotech 
Amersham Pharmacia Biotech 
VWR Scientific 
Innova 
Eppendorf 
VWR Scientific 
Lab-Line 
QIAgen 
QIAgen 
Fisher Scientific 
VWR Scientific 
Biochrom 
VWR Scientific 
Resin 
DE52 anion exchanger (DEAE cellulose) 
His-Select Nickel Affinity Gel 
 
Whatman 
Sigma 
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4.2 Common Procedures Used  
4.2.1 Agarose gel electrophoresis 
1-1.5% (w/v) agarose gels were prepared in 1X TAE buffer (40 mM Tris-acetate, 1 mM 
EDTA, pH 8.0). The solution was boiled until the agarose was completely dissolved in the 
buffer. Ethidium bromide (0.5 μg/mL) was added and mixed properly when the agarose 
solution cooled down. The cooled, liquified gels were then allowed to set in the gel cast by 
pouring and the cascade was properly sealed to prevent leaking. DNA samples were mixed with 
1X loading buffer [0.04% (w/v) bromophenol blue, 5% (v/v) glycerol]. Different volumes of 
samples were loaded on the gels depending on the type of sample and purpose of the gel. DNA 
samples were resolved on the agarose gel at 120 V for 15-20 min in 1X TAE buffer. The gel-
resolved samples were visualized and analyzed with a GelDoc UV illuminator. For the DNA 
gel extraction procedure, samples were viewed with a UV lamp at 365 nm and cut from the gel 
for purification.       
 
4.2.2 Colony PCR (Polymerase Chain Reaction) 
Colony PCR was performed with single colonies (colony forming units) of transformed 
XL1-Blue cells containing cloned plasmid to confirm that the correct gene was inserted into the 
vector. The transformed cells were grown on Luria-Bertani (LB) agar plates containing the 
appropriate antibiotics. Forward and reverse primers used for colony PCR had overlapping 
regions from the plasmid vector that would produce a PCR product containing the gene if it had 
been positively cloned. We used the pET28a-c(+) plasmid vector for all cloning purposes used 
with this technique. pET28a-c(+) has a T7 promoter site and a T7 terminator site (Figure 4.1B); 
we designed primers for these two sites of the vector. The primers are shown in the Table 4.2. 
 
Table 4.2 Sequences of the primers used for colony PCR. 
Construct Sequence (5′-3′) 
T7 Promoter taa tac gac tca cta tag gg 
T7 Terminator gct agt tat tgc tca gcg g 
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Single colonies were picked from the LB plate and resuspended in 6 μL of double 
distilled water (ddH2O). Four microliters of the resuspended colony were added to a PCR 
mixture with a final volume of 25 μL. The reaction volume consisted of 1 unit (U) of Taq DNA 
polymerase, 100 μM of each dNTP, 1X Thermo-Pol Reaction Buffer, 1 μM of each of the 
primers. The DNA containing the inserted gene was amplified by a PCR Thermocycler using 
the following cycles: 94°C for 2 min; 25 cycles of 94°C for 45 sec, 55°C for 1 min, 72°C for 1 
min; 72°C for 10 min. The PCR products were resolved with a 1% agarose gel and the DNA 
bands were viewed under UV light in the GelDoc.  
 
4.2.3 Protein crystallization by vapour diffusion 
Vapor diffusion is the most commonly used method to crystallize proteins.  Water is 
allowed to evaporate from a protein solution to a larger reservoir solution; this makes the 
protein more concentrated in order to facilitate crystal formation. A drop (small reservoir) of 
protein solution is set on top of a larger reservoir, either hanging from a cover slide on top of 
the larger reservoir or sitting on another smaller well. The larger reservoir has a higher 
concentration of buffer and precipitant. This leads to the evaporation of water molecules from 
the protein drop to the well solution. Therefore, the concentration of protein in the drop 
increases and the protein tends to precipitate and form crystals (Rhodes, 1993; McRee, 1993). 
There are two ways to perform the vapor diffusion crystallization procedure, hanging drop 
method and sitting drop drop. They differ only in the way the drops are set. Notice that the 
crystallization environment is a closed system. The protein drops hanging from the cover slide 
on top of the well solution is the hanging drop method. On the other hand, a protein drop sitting 
on a smaller well is the sitting drop method. There are several commercial kits available to set 
up a crystal plate by the sitting drop method. Usually 96-well kits are used for the non-robotic 
sitting drop crystallization procedure and are what we used in our part of the co-crystallization 
trials.    
 
 35 
 
4.2.4 LB Media Preparation 
Luria-Bertani (LB) (Miller) broth was prepared in one of two ways. One way was to 
mix the ingredients [10 g Bacto-tryptone, 5 g yeast extract and 10 g NaCl] in a final volume of 
1 liter of water.  Another way was by dissolving commercially prepared LB Miller powder in 
water. The broth was autoclaved at 15 psi and 121°C for 30 minutes. Essential antibiotics were 
added to cooled autoclaved broth before culturing the cells. Agar medium was prepared by 
adding 15 g of Bacto-agar to 1 L of LB broth. 
 
4.2.5 SDS-PAGE 
Protein samples were prepared before running the protein gels. The proteins were mixed 
with 5X loading buffer [10% SDS (w/v), 10 mM β-Mercaptoethanol, 20% Glycerol (v/v), 0.2 
M Tris-HCl, pH 6.8, 0.05% Bromophenol blue] to reach a final concentration of 1X.  The 
protein samples were boiled for 5 minutes after adding the loading buffer and then loaded in the 
gels. Gels were first run at 30 V for 20 minutes and then at 120 V for 40 minutes. The gels were 
stained with staining buffer [0.25% (w/v) Coomassie Brilliant Blue R-250, 45% ethanol and 
10% glacial acetic acid] for 2 hours and then destained with destaining buffer [40% ethanol and 
10% glacial acetic acid] overnight.    
Two types of protein gels were used in our study. We called the two types of gels 
Glycine-SDS-PAGE and Tricine-SDS-PAGE (Schägger, 2006). The principal difference 
between these two procedures was the use of Glycine or Tricine in the gel running buffer.  
 
4.2.5.1 Glycine-SDS-PAGE 
Glycine-SDS PAGE was performed by preparing the resolving gel, stacking gel and a 
running buffer. The ingredient compositions are listed in the Table 4.3. 
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Table 4.3 Ingredients and amounts for the components prepared for Glycine-SDS-PAGE. 
12 % resolving gel  
H2O 10.2 mL 
1.5 M Tris-HCl, pH 8.8 7.5 mL 
20% (w/v) SDS 0.15 mL 
Acrylamide/Bis-acrylamide (30%/0.8% w/v) 12.0 mL 
10% (w/v) ammonium persulfate (APS) 0.15 mL 
TEMED 0.02 mL 
Stacking gel  
H2O  3.075 mL 
0.5 M Tris-HCl, pH 6.8 1.25 mL 
20% (w/v) SDS 0.025 mL 
Acrylamide/Bis-acrylamide (30%/0.8% w/v) 0.67 mL 
10% (w/v) ammonium persulfate (APS) 0.025 mL 
TEMED 0.005 mL 
1X Running buffer  
Tris-Cl, pH 8.0 25 mM 
Glycine 200 mM 
SDS 0.1% (w/v) 
 
 
4.2.5.2 Tricine-SDS-PAGE 
Three types of buffers were prepared for this protocol. Two of them were running 
buffers (electrodes) and were called the ‘anode buffer’ and ‘cathode buffer’. Another one is the 
gel buffer, which is necessary for gel making. Anode buffer was poured outside the gel (the 
space in between the gels and the tank) and cathode buffer was poured in between the two gels. 
The buffer components are listed in the Table 4.4. 
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Table 4.4 Ingredients of the buffers used for Tricine-SDS-PAGE. 
 Anode Buffer (10X) Cathode Buffer (10X) Gel Buffer (3X) 
Tris (M) 1.0 1.0 3.0 
Tricine (M) ---- 1.0 ---- 
HCl (M) 0.225 ---- 1.0 
SDS (%) ---- 1.0 0.3 
pH 8.9 ~8.25 8.45 
 
The gels were prepared according to the following protocol. 
 
Figure 4.5 Ingredients for Tricine-SDS-PAGE preparation. 
 Stacking gel (4%) 10% 16% 
AB-3:Acrylamide/Bis-acrylamide 
(48%/1.5% w/v) 
 
(mL)
 
1 
 
6 0 
Gel buffer (3X) (mL) 3 10 0 
Glycerol (g) ---- 3 3 
Add water to final volume (mL) 12 30 0 
10% APS (μL) 90 150 0 
TEMED (μL) 9 15 10 
 
4.3 Cloning 
A truncated LexA, Δ68LexAK156A, was previously introduced into the pET28a-c(+) 
vector (Novagen) in our laboratory by Gloria Qian. The first 68 amino acids were removed 
from LexA to truncate the DNA-binding domain and the K156A mutation was introduced to 
make the LexA mutants non-cleavable (termed as ∆68LexAK156A). The map and the cloning 
region of the pET28a-c(+) vector is shown in Figure 4.1. The position of the LexA gene 
inserted is also marked in Figure 4.1A. The gene for kanamycine resistance helps the clone 
selection during cloning process. The cloning region shows the essential cutting sites, His-tag 
positions and the position of T7 promoter and T7 terminator (Figure 4.1B).  
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Figure 4.1 pET28a(+) plasmid vector map and cloning region in the vector. 
A) The 5.4 kb pET28a(+) bacterial protein expression vector is shown here. It contains a short 
cloning/expression region (shown in Figure B). The vector encodes a Kanamycine resistence 
gene (KanR2). It has a short region containing several restriction cutting sites. The position of 
the ∆68LexAK156A gene inserted in to the vector is shown here. ∆68LexAK156A gene was 
inserted in between the Xho I and Nde I cutting sites (black arrows). B) The cloning/expression 
region of the pET28a-c(+) is shown. The region has a both N- and C- terminal His-Tag site. 
The cutting regions and T7 promoter and terminator regions are also given. Courtesy of 
Novagen (www.emdchemicals.com/showBrochure?id=200905.345). 
 
 
Xho I 
Nde I 
∆68LexAK156A
A 
B 
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Two β-11 strands of the CTDs of the LexA dimer interacts antiparallely in the dimer 
interface (Figure 4.2) (Luo et al., 2001). Three consecutive residues Val195, Ile196 and Arg197 
are found in the C-terminal end positions of the β-11 stand which also takes part in the 
antiarallel β-11 strand interaction. Therefore, mutations were targeted for these three residues. 
The targeted mutations were Valine195 to Proline (V195P), Isoleucine196 to Tyrosine (I196Y) 
and Arginine197 to Proline and Glutamine (R197P and R197Q). V195P and R197P mutations 
were chosen to break down the hydrogen bonding between the two antiparallel β-11 strands and 
with other residues (Figure 4.2B-C). I196Y was chosen to produce steric hindrance in the dimer 
interface (Figure 4.2B) and R197Q was chosen to break down the hydrogen bonding with 
Gly124 (Figure 4.2C). The sequences of the forward and reverse primers for the mutations are 
listed in Table 4.6.  
 The forward primers had an Nde I restriction site and the reverse primers had an Xho I 
restriction site. Since the mutation sites were close to the end of the C-terminal end of LexA, 
mutations were introduced only in the reverse primers. The forward primer was designed by 
and obtained from Gloria Qian and was the same for all four mutations. No start codon was 
introduced in the forward primer because that would encode the hexa-histidine tag from the 
vector into the N-terminal site of the proteins. Table 4.6 contains the list of the primers used for 
cloning purpose. 
 
 
Table 4.6 Sequences of the primers used for cloning of the LexA mutants. Restriction 
cutting sites and the coding sequences are shown in bold and italic letters, respectively. The 
mutation codons are underlined. 
 
Name Sequence (5′-3′) Restriction sites 
∆68LexA For gga att cca /tat gca gga aga gga aga agg gtt Nde I 
V195P Rev ccg c/tc gag tta cag cca gtc gcc gtt gcg aat agg ccc aac Xho I 
I196Y Rev ccg c/tc gag tta cag cca gtc gcc gtt gcg ata aac ccc aac Xho I 
R197P Rev gtg c/tc gag tta cag cca gtc gcc gtt agg aat aac ccc aac Xho I 
R197Q Rev gtg c/tc gag tta cag cca gtc gcc gtt ttg aat aac ccc aac Xho I 
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Figure 4.2 Dimer interface of E. coli LexA and the interactions involving antiparallel β-11 
strands.  
A) Two CTDs of LexA interacting in the dimer interface to form a dimer (PDB ID: 1jhh, Luo et 
al., 2001). Top and bottom monomers are shown in purple and cyan, respectively. ~1380 Å2 
area is buried in the dimer interface (Luo et al., 2001). The interface region (residues from two 
loops: Gln99 to Asp110 and Ser116 to Gly128, and part of the antiparallel β-11 strands) that are 
buried and interacting in the dimer interface are shown in green (light green in top monomer, 
dark green in bottom monomer). Two antiparallel β-11 strands are shown in red except for the 
part interacting in the dimer interface (green). Figure B and C are cartoon representation of the 
antiparallel β-11 strands showing the interactions. Residues Val195 to Arg197 are presented in 
ball and stick model in figure B. Polar interactions between these residues are shown in yellow 
dotted lines. Arg197 from one strand interact with Val195 of the other strand by two hydrogen 
bonds and vice versa. Figure C shows a different interaction between the Arg197 with the 
Gly124, donated from a loop (Ser116 to Gly128) in the dimer interface. Gly124 from one 
monomer forms two hydrogen bonds with the two side chain nitrogens of Arg197 from another 
monomer. One hydrogen bond was found between Gly124 and Arg197 from the same 
monomer. The residues that were targeted for mutations in the current experiment were Val195, 
Ile196 and Arg197 to interrupt the interactions in the dimer interface of two monomers of 
LexA. Figures were created by PyMOL.   
A B 
C 
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The genes were amplified by the PCR technique as described by Sambrook and Russel 
(2001). Pfu DNA polymerase was used for the chain reaction. All the PCR products were 
extracted and purified from 1% agarose gels (w/v) with the Qiaquick gel extraction kit. Both 
the PCR products and the pET28a-c(+) vector were double-digested with Nde I and Xho I [2.5 
μL 10X Buffer No. 4, 100X BSA, 1 μL Nde I, 1μL Xho I and 20 μL PCR products, incubated 
overnight at room temperature]. The cut vector was then ligated to the cut PCR products by T4 
DNA ligase [1 μL Ligase buffer, 1 μL T4 Ligase, 6 μL digested fragments and 2 μL digested 
vector, incubated 5 hours at 37°C]. Ligated products were then transformed into XL1-Blue E. 
coli competent cells by electroporation with 1600 volts of electric impulse. After the 
electroporation, each batch of cells (50 μL) was first cultured in 400 μL of SOC culture 
medium [20 g Bacto-Tryptone, 5 g Yeast extract, 0.5 g NaCl, 2.5 mL of 1 M KCl, ddH2O to 1 
L]. After one hour of incubation at 37°C, the cultures were transferred to LB agar plates 
containing 35 μg/mL kanamycin (spread plate method) and grown overnight at 37°C. A few 
colonies were selected and marked on the plate after growth and picked to start colony PCR. 
This time, the T7 promoter and the T7 terminator (Table 4.2) primers were used and Taq DNA 
polymerase was used for the elongation process. The PCR products were resolved with 1% 
(w/v) agarose gels and the band sizes were compared with the ladder. The positive colonies 
were picked from the plates and grown in LB broth (with 35 μg/mL kanamycin) overnight at 
37°C in the Orbit Environ Shaker at 150 rpm. Plasmids were purified from the grown XL1-
Blue cells using the Qiagene plasmid extraction kit. Sequences were confirmed by sending the 
DNA samples to the DNA Laboratory of the Plant Biotechnology Institute (PBI), Saskatoon, 
Canada.  Purified plasmids containing the desired genes were electroporated into Rosetta (DE3) 
cells as described above and grown in SOS medium for an hour at 37°C with occasional 
shaking. The culture was transferred to 10 mL of LB broth. After 1 hour of growth at 37°C with 
shaking, 35 μg/mL kanamycin and 30 μg/mL chloramphenicol were added to the medium and 
incubated at 37°C overnight at 150 rpm. 800 μL of grown culture were added to a small tube to 
create a stock and stored with 20% glycerol at -80°C.    
The wild-type RecA and wild-type LexA genes were obtained from the lab and were 
previously cloned between the Nde I and Xho I restriction sites of the pET28a-c(+) vector. In 
contrast to the lexA genes, recA gene had C-terminal hexa-histidine tag to facilitate binding to a 
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Ni2+ charged affinity column. Two other LexA mutant genes, ∆68LexAK156A and 
∆68LexAK156AI196K, were also obtained from the lab and purified same way as the other 
LexA mutants. 
 
4.4 Expression of the proteins 
With the sterilized pipette tip, a tiny amount of the frozen electroporated Rosetta (DE3) 
cells containing the LexA mutant genes was transferred from the stock to 50 mL of LB medium 
containing 35 μg/mL kanamycin and 30 μg/mL chloramphenicol and incubated at 37°C 
overnight in a shaking incubator. One liter of LB medium was inoculated with 25 mL of the 
overnight cultures. Throughout the culturing, 35 μg/mL kanamycin and 30 μg/mL 
chloramphenicol were always added to the growth.  Inoculated cultures were grown at 37°C in 
the shaking incubator until the absorbance of the culture reached 0.5 at 590 nm wavelength. To 
induce protein expression, 0.25 mM IPTG was added to the cultures, which were incubated for 
an additional 3-4 hours under the same conditions. After induction, the cells were collected 
from the liquid culture by centrifugation at 4000 X g for 20 minutes at 4°C. The pellets were 
collected in a separate tube and stored at -20°C until protein purification. Wild-type RecA, 
wild-type LexA, Δ68LexAK156A and Δ68LexAK156AI196K proteins were also expressed by 
the same method. 
 
4.5 Protein purification 
The collected cell pellets were first taken out from the -20°C freezer and resuspended in 
binding buffer [0.5 M NaCl, 30 mM Tris-Cl, pH 7.8]. Lysozyme (10 mg/mL) was added and 
the cells were sonicated with a Sonic Dismembrator at 70% amplitude for a cycle of 3 minutes 
(pulse on) in a 3 second pulse and 6 second rest for 3-5 times until the cells were broken open. 
The sonicated products were centrifuged at 31000 X g for 20 minutes. Supernatants were 
collected and eluted from a DE52 anion exchange column to get rid of residual DNA. The 
anion exchange column was previously equilibrated with the binding buffer. The flowthrough 
from the anion exchange column was then passed through a nickel affinity column. The nickel 
affinity column was first charged by running binding buffer and then a 0.1 M NiSO4.6H2O 
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solution over the column. The unbound nickel was removed by running binding buffer over the 
column again. The column with the bound histidine-tagged protein was then washed with a 
sufficient volume (~200 mL) of washing buffer [10 mM Imidazole, 0.5 M NaCl, 30 mM Tris-
Cl, pH 7.8] to elute all the unbound proteins and impurities. Bound proteins were then eluted 
from the column by washing with elution (stripping) buffer [0.5 M NaCl, 50 mM EDTA, pH 
7.8]. The eluted proteins were incubated overnight with thrombin (1 U/mg) at room temperature 
to remove the histidine tag from the protein. The proteins were run on 13% protein gels 
(Glycine-SDS-PAGE) to confirm the cleavage. After cutting, the DE52 anion exchange column 
was run to get rid of the thrombin. The buffer salt gradient ranged from 0.05 M to 0.5 M NaCl. 
The protein fractions were collected and precipitated overnight with 35% (w/v) ammonium 
sulfate. The precipitates were collected by centrifugation at 31000 X g at 4°C. The precipitates 
were redissolved in elution buffer [0.1 M NaCl, 30 mM Tris-Cl, pH 7.8, 0.1% β-
Mercaptoethanol] for gel filtration chromatography and eluted from the HiPrep Saphacryl S-
100 column. The flow rate was set 1 mL/min. Protein fractions of the intended size were 
collected, while avoiding the void volume.  
The histidine tag was not removed during the purification of wild-type RecA. The other 
procedures followed for RecA purification were the same as those for the LexA proteins, but 
RecA had to be eluted from a HiPrep Saphacryl S-300 column due to its larger size (37.8 kD) 
and its tendency to form a hexamer. The buffer used for this purpose was also different and 
contained 1 M Urea, 1 M NaCl, 30 mM Tris-Cl, pH 7.8 and 0.1% β-Mercaptoethanol. Protein 
fractions from the profile peak were collected.  
All the proteins from the gel filtration elution were concentrated with Millipore 
centrifuge filter tubes (45 μm pore size) until the protein concentration reached 20 mg/mL. 
Finally, the purified proteins were stored at -80°C. 
 
4.6 Size exclusion chromatography profile analysis and comparison  
Gel filtration or size exclusion chromatography separates protein according to size; the 
larger proteins elute from of the column earlier. Therefore, multimers should be eluted before 
monomers. As a result, the volume of buffer needed to elute proteins should differ according to 
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different forms of oligomerization. Therefore, the position of the peak of the protein in the 
elution profile should be different based on the monomeric, dimeric or multimeric forms. LexA 
mutants (Δ68LexAK156A, Δ68LexAK156AI196K, Δ68LexAK156AV195P, 
Δ68LexAK156AI196Y, Δ68LexAK156AR197P and Δ68LexAK156AR197Q) were eluted 
through the HiPrep Saphacryl S-100 gel filtration column during purification. The elution 
profiles of the different mutants were saved and the volumes of buffer (mL) that were need for 
the elution of the LexA mutants were recorded. The volume profiles of the four LexA mutants 
(Δ68LexAK156AV195P, Δ68LexAK156AI196Y, Δ68LexAK156AR197P and 
Δ68LexAK156AR197Q) were compared with the previously analyzed (in the current lab) 
known predominantly dimeric (∆68LexAK156A) and monomeric (∆68LexAK156AI196K) 
LexA mutants. 
 
4.7 Dynamic Light Scattering (DLS) technique 
Dynamic light scattering provides information about the size of any particle in solution 
by measuring the hydrodynamic radius. The percentage of the monomeric or oligomeric forms 
of the LexA mutants can therefore be measured in solution by using this method. Three 
different concentrations of each LexA mutants were analyzed: 200, 100 and 33.3 μM. The 
dilution buffer for the LexA mutants contained 50 mM HEPES-Tris, pH 7.8 and 0.1 M NaCl 
and was subsequently filtered with 0.45 μm pore size polyvinylidene difluoride filters 
(Millipore). The LexA mutants were diluted in the buffer, centrifuged for 4 minutes at 4000 X g 
and then filtered with a 0.02 μm Anodisk filter before starting the experiment. The DLS 
measurements were performed at 25°C with a DynaPro MS800 instrument.  The instrument 
used an 824.8 nm laser diode, which was operated at a power of 55 mW and had a fixed 
scattering angle of 90 degrees.  Scattered intensity was accumulated at intervals of 5 sec for a 
period of 6 minutes.  The particle size distribution was analyzed with Dynamics V5.26.60, 
which was supplied by the manufacturer. The mass percentage of the different sized LexA 
mutants (monomeic, dimeric and tetrameric) in the solution was produce by the software at 
different concentrations and the dimer dissociation constant (Kd) was revealed from the 
concentration and mass percentage of the protein. 
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4.8 Co-protease assay of wild-type LexA 
Wild-type RecA and LexA were allowed to interact in a reaction procedure called the 
co-protease assay. The prepared reaction solution consisted of 50 mM HEPES-Tris buffer, pH 
7.4, 20 mM MgAc2, 2 mM AMPPNP, 1 μM dT 45 (ssDNA), 10 μM wild-type RecA and 20 
μM wild-type LexA. All the ingredients were first combined in a tube and mixed gently by 
pipetting. AMPPNP, an analog of ATP, was the last component added in order to start the 
reaction. The phosphodiester bond between the β- and γ -phosphate of ATP breaks down during 
the ATPase activity by proteins, such as RecA. AMPPNP, full name Adenylyl-
imidodiphosphate, has a nitrogen (N) atom instead of oxygen (O) in between the β- and γ-
phosphate group of ATP (Figure 4.3). The presence of the nitrogen atom makes the molecule 
resistant to phosphodiester bond breakdown and γ-phosphate cannot be released as a leaving 
group. Therefore, AMPPNP was used in the experiments stabilize the reaction rate. Replacing 
the same oxygen (O) atom with carbon (C) also makes the molecule hydrolysable by ATPase 
activity and the molecule is called AMPPCP. The structures of ATP, AMPPNP and AMPPCP 
are presented in Figure 4.3. 
 
 
 
 
 
 
 
 
 
 
 
Figure 0.1 Structure of ATP and its analogs. 
Chemical structures of the ATP, AMPPNP and AMPPCP are shown. Positions of oxygen (O), 
nitrogen (N) and carbon (C) atoms between the γ- and β-phosphate groups are indicated with 
the arrow in ATP, AMPPNP and AMPPCP, respectively. These figures were created with 
Online Chemical Editor (JChemPaint). 
ATP AMPPNP AMPPCP 
CH2 
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One negative control reaction solution was also prepared without any AMPPNP. The 
proteins were allowed to interact while the solution was kept at room temperature (~20°C) for 2 
hrs. The reaction was stopped by adding 1X protein loading dye. Tricine-SDS-PAGE was 
performed to analyze the cleavage. 13% Tricine-SDS polyacrylamide gel was used and the gel 
was Coomassie stained. The gels were viewed and pictures were captured and analyzed by the 
Kodak GelDoc imaging system.   
 
4.9 Time course co-protease assay 
A time course co-protease assay was performed with the same reaction solutions and 
conditions as in the previous experiment. The reaction was also allowed to continue for 2 hours. 
However, samples were taken at 30 minutes intervals from 0 min to 120 minutes. Therefore, 5 
total samples were collected from one reaction. The reaction was stopped at different intervals 
by adding 2X protein loading dye and placing the tube on ice until the protein gel was run. 
Tricine-SDS-PAGE was performed to monitor the cleavage of LexA with respect to time. 
Pictures were captured as described above and the band sizes were analyzed.  
 
4.10 Co-protease inhibition assay 
If the non-cleavable LexA mutants bind tightly to RecA, they will occupy the binding 
sites for wild type LexA. Therefore, RecA-mediated cleavage of wild type LexA will be 
inhibited, and the mutants will act as inhibitors of co-protease activity. The co-protease 
inhibition assay is the same as the co-protease assay except for the addition of inhibitors, i.e., 
the LexA mutants. For this purpose, 2 mM AMPPNP and 10 μM of inhibitors (LexA mutants) 
were added before addition of wild type LexA to the reaction solution. The mixture was 
incubated for 3 minutes at room temperature to allow the mutants to bind to RecA. Then, wild 
type LexA was added, mixed gently, and incubated for 2 hours at room temperature. Inhibitory 
capability was measured by running the samples on 13% Tricine-SDS acrylamide gels. A time 
course of inhibition was also performed by sampling the reactions in 30-minute intervals for a 
total time of 2 hours. All of the gel pictures were captured and the band sizes were analyzed.  
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4.11 Co-crystallization attempts of RecA and LexA  
For the RecA and mutant LexA co-crystallization attempts, 24-well crystallization 
plates for the hanging drop method and 96-well plates for commercial crystallization kits for 
the sitting drop method were used. Protein solutions contained 10 μL of RecA (~20 mg/mL), 10 
μL of LexA (~20 mg/mL), 1 mM ATP or analogues and 1 mM of ssDNA of different sizes. 
Well solutions contained different concentrations of buffers, precipitants, and salts. The 
conditions that were used for the hanging drop method are given in Table 4.7. 
Two different commercial kits from Qiagene/Nextal were used, The Classics and The 
Pegs. The plates contained 96 wells for 96 different conditions for each kit. The compositions 
and ingredients of the kit solutions can be found on the Qiagen webpage 
(http://www1.qiagen.com). 
Around 0.8 μL of protein solution and 0.8 μL of well solution were used to make one 
crystallization drop. The wells were sealed with grease-mounted cover slips for the hanging 
drop method and adhesion tape for the sitting drop method. The plates were incubated at room 
temperature and observed under a microscope at regular periods. The conditions and changes 
during the incubation period in each well were recorded. The conditions were repeated if 
crystals were found in any of the drops. We tried to purify the proteins in different buffers, such 
as buffers containing acetates instead of chlorides or potassium instead of sodium, to facilitate 
crystallization.  
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Table 4.7 Ingredients and conditions applied for the co-crystallization trials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crystallization Trials  
Protein Solution  
Components Varying components 
 
LexA mutants 
 
I196Y 
R197P  
 
ATP or analogues  
 
ATP 
AMPPNP 
ADP 
ADP + AlF4  
AMPPCP  
 
ssDNA (dT## are nt 
numbers) 
 
dT45 
dT22 
dT20 
dT18 
Well Solution 
 
 
Components Varying 
components 
Varying parameters 
 
Buffers 
 
HEPES 
HEPES-Tris  
Tris  
MES  
pH 
6.0-8.5 
 
Precipitants 
 
PEG 550 
PEG 1500 
PEG 3350 
K15 
Ethylene Glycol  
Concentration 
PEG and K15: 8-30% 
Ethylene Glycol: 20-
60%  
 
Salts 
 
NaCl  
KCl  
NaAc  
KAc  
MgCl2  
MgAc2  
Concentration 
0-0.2M  
 49 
 
Chapter Five: Results 
5.1 Mutagenesis, cloning, expression and purification of the RecA, wt LexA, and six LexA 
dimer interface mutants (∆68LexAK156A mutants) 
RecA, wild type LexA and six of the LexA dimer interface mutants (∆68LexAK156A, 
∆68LexAK156AI196K, ∆68LexAK156AV195P, ∆68LexAK156AI196Y, ∆68LexAK156AR197P 
and ∆68LexAK156AR197Q) were purified. ∆68LexAK156AV195P, ∆68LexAK156AI196Y, 
∆68LexAK156AR197P and ∆68LexAK156AR197Q mutants were freshly cloned and the other 
two mutants (∆68LexAK156A, ∆68LexAK156AI196K) were collected as pre-cloned (Moya, 
2006) in the lab. Expressions of all the proteins in Rosetta (DE3) cells were sufficient to purify 
substantial amount of proteins. All proteins were soluble in the buffer solution [0.5 M NaCl and 
30 mM Tris (pH 7.8)] after cell disruption by sonication (Figure 5.1, lane 4). Supernatant from 
the cell lysate was applied to the anion exchange column DE52 to remove the negatively 
charged dissolved DNA fragments from the solution. Positively charged proteins flowed 
through the column (Figure 5.1, lane 5).  
 
 
 
 
 
 
 
 
 
 
Figure 5.1 A typical SDS-PAGE gel of the primary purification steps of RecA. 
This is a 12% Glycine-SDS polyacrylamide gel and the gel was stained with Coomassie 
Brilliant Blue R250. 20 μL of samples were loaded in each well.  
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Nickel chelating column chromatography produced reasonably pure protein, and size 
exclusion chromatography increased the purity to >90%. Samples from the different steps from 
cell disruption to nickel chelating column purification were collected and analyzed by Glycine-
SDS-PAGE. Figure 5.1 shows different purification steps of wild type RecA. The purity gel 
shows the yield and purity of the proteins collected from nickel column flow through (Figure 
5.2). 20 μL of protein samples were loaded in each well and the concentration of the proteins 
were not standardized. The yield and purity after this step differed from protein to protein.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Purity of proteins after nickel chelating column chromatography. 
The proteins were collected after the nickel chelating column run. 12% Glycine-SDS 
polyacrylamide gel was run and the gel was stained with Coomassie Brilliant Blue R250. 20 μL 
of proteins were loaded in each well. The concentrations were not standardized.  
 
The final step of the purification before concentrating the protein was the gel filtration 
chromatography. The HiPrep Saphacryl S-100 column profile showed different elution volume 
for different mutants. Figure 5.3 shows the elution profile of ∆68LexAK156AV195P and two 
peaks can be seen during protein elution. The first early peak was the void volume due to the 
impurities of the proteins. It was eluted around 35 to 40 mL range usually. This peak was not 
175 
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collected. The second peak was eluted at least after 50 mL of elution and was pooled for 
concentration.   
 
 
 
 
 
 
 
 
 
  
 
 
Figure 5.3 Gel filtration elution profile of ∆68LexAK156AV195P.  
The UV absorption unit (mAu) against buffer elution (mL) graph of the S-100 HiPrep 
Saphacryl column is shown. Two peaks represent the elution of proteins. The early peak was 
due to the impurities and the second peak represents the monomeric/dimeric form of the LexA 
mutants. The fractionation range (Mr) of the S-100 column for the globular protein is 1 X 103 – 
1 X 105. 
 
Purified LexA dimer interface mutants with N-terminal hexa-Histidine tags had a milky 
appearance in solution. When the His-tag was cut off from the mutants by thrombin treatment, 
the purified protein solutions became clear. This reveals that the aggregation of the LexA 
mutants was due to the N-terminal Histidine tag.    
 
5.2 Gel filtration chromatography elution profile analysis 
Size exclusion or gel filtration chromatography has become a remarkable tool for 
macromolecular purification since it was developed during the late 1950s (Hagel, 2001; Porath 
and Flodin, 1959). As the name indicates, size exclusion chromatography separates molecules 
according to size; therefore, this method can be used to measure the size of macromolecules.  
 
                35              40             45             50              55             60             65            70 Volume (mL) 
mAu 
Void volume
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This principle was used in our study to determine the sizes of the purified LexA mutants. 
Larger molecules, such as oligomers of LexA, elute earlier from the gel filtration column with a 
smaller solution volume than smaller molecules. As a result, polymers of a protein should elute 
from the column with a smaller solution volume than the monomers. This can indicate whether 
any protein is monomeric or polymeric.   
In this experiment, the LexA mutants were applied to the gel filtration HiPrep Saphacryl 
S-100 column during purification, and the resulting gel filtration profiles were compared with 
the different LexA mutants. Two peaks appeared in most of the protein profile (Figure 5.4). The 
first peak appeared due to impurities of the protein. Proteins from the second peak were 
collected, which was assumed to give monomeric and/or dimeric proteins at the purification 
concentration. The profiles got from the gel filtration protein elution were used for the size 
determining experiment of the mutants.   
The gel filtration graph profiles are shown in Figure 5.4. The ∆68LexAK156A and 
∆68LexAK156AI196K mutants were analyzed previously in our lab (data not shown), and gel 
filtration profiles of dimeric and monomeric LexA species, respectively, were found. The 
mutant proteins produced in this study were compared with these two controls in the same 
buffer system. The V195P, I196Y and R197Q mutants had elution volumes that were similar to 
the dimeric control and are presumed to be polymers in solution. The elution profile of the 
R197P mutant was more similar to the previously characterized I196K monomer. Interestingly, 
both these mutants had a small bump/peak before the final peak at around 50 mL region. The 
I196K peak started earlier and showed an elongated buffer volume range which indicates that 
there may be more than one peak. R197P also showed a smalled peak before larger. This 
indicates that there may be more than one form of LexA present in these solutions. Note that 
the I196Y mutant was eluted with a little more solution than the dimeric control but less than 
the monomeric control (Figure 5.5). 
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Figure 5.4 Gel filtration elution profiles of ∆68LexA mutants. 
The gel filtration elution profiles of six LexA mutants are presented. The volume (mL) of the 
buffer needed for the protein elution is shown on top of each peak. The elution volume (mL) 
was determined by pointing the volume needed for the appearance of the top of the peak. Some 
ghost peaks appeared due to the impurity or higher oligomerized state. HiPrep Sephacryl S-100 
column was used for the protein elution. The fractionation range (Mr) of the S-100 column for 
the globular protein is 1 X 103 – 1 X 105. 
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Figure 5.5 Graphical presentation of gel filtration chromatography sample elution volume 
profile. 
The graph shows the comparative volumes (mL) of buffer that were required for the elution of 
different ∆68LexAK156A mutants from the HiPrep Sephacryl S-100 column. 
 
5.3 Dynamic Light Scattering (DLS) experiments 
Dynamic light scattering is a more accurate technique to measure the size of particles or 
molecules in solution than gel filtration. Particles in solution undergo Brownian motion. If laser 
light is applied to a protein solution, the intensity of the light scattered by the particles 
fluctuates. The fluctuation of the light intensity depends on the size of the particles in the 
solution. Analysis of this fluctuation yields the velocity of the Brownian motion, and the size of 
the particles or molecules can be measured using the Stokes-Einstein equation. The size is 
determined from the hydrodynamic radius or diameter of the molecules in the solution, which 
refers how a particle diffuses in a fluid.  
The particle size distribution analyzer provides the size of the protein molecules in 
molecular weight. Therefore, it is possible to determine the monomeric or polymeric form of 
∆68LexA Mutants 
Vol (mL) 
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proteins from known molecular weights. Truncated mutant LexA monomers have a molecular 
weight of ~15 kDa.  
The DLS data of the four ∆68LexAK156A mutants at 33.3 μM concentration are 
presented in Figure 5.6 as pie charts. DLS data from all the mutants at different concentrations 
are tabulated in Table 5.1 and presented in the Figure 5.7. A previous study in our lab (data not 
shown) (Moya, 2006) and the current study showed that ∆68LexAK156A is predominantly a 
dimer (~65% dimeric) at 33.3 μM. In the current study, ∆68LexAK156AR197P was found as 
predominantly monomeric in solution at concentrations of both 33.3 μM and 100 μM (60% and 
50% of the mass respectively) (Figure 5.6 and 5.7, Table 5.1). The ∆68LexAK156AI196Y 
mutant was also 49% in the monomeric form at 33.3 μM.  The other two mutants were 
predominantly dimeric or tetrameric at 33.3 μM and higher concentrations.  
 
 
  
 
 
 
 
 
 
 
 
 
Figure 5.6 Percentages of the different forms of the ∆68LexA mutants at 33.3 μM 
concentrations in solution. 
The pie charts were generated with the data from the DLS profiles of the different LexA 
mutants. The R197P and I196Y mutants show high monomeric mass percentages in solution at 
33.3 μM, whereas the other two mutants show higher oligomeric mass percentages. 
 
Monomer       Dimer       Tetramer
60%
30%
10%
K156AR197P 
18%
70%
12%
K156AR197Q
48%
38%
14%
K156AI196Y 
93%
7%
K156AV195P 
14%
61%
25%
K156A
 Monomer       Dimer        Tetramer 
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Table 5.1 Dynamic light scattering data of five ∆68LexA mutants.  
Diffusion coefficient, hydrodynamic radius, molecular weigth, mass percentage and dimer 
dissociation constant (Kd) of different oligomeric forms of LexA mutants in three different 
concentrations are shown here. Dimer dissociation constant (Kd) values were estimated based 
on the mass distribution. Kd values at concentrations that showed absence or very low 
percentage of monomeric proteins were omitted. 
 
*15.5 kD = Monomer, 30.7 kD = Dimer, 60.7 kD = Tetramer. 
 
 
Mutant LexA Concentration (uM) Diff (e-9cm2/s) Hydrodynamic radius 
(nm)
Molecular weight 
(kDa) * 
% mass Kd (μM) 
K156A  33.3  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
13.96  
59.26  
24.08  
2.18 
 
100  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
1.63  
82.70  
15.67  
-- 
 
200  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
0.00  
80.66  
19.34  
-- 
K156AV195P  33.3  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
0.00  
93.42  
6.58  
-- 
 
100  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
0.00  
87.75  
12.25  
-- 
 
200  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
0.00  
92.63  
7.37  
-- 
K156AI196Y  33.3  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
48.11  
38.27  
13.62  
40.28 
 
100  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
19.84  
63.36  
16.80  
12.42 
 
200  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
7.35  
75.42  
17.23  
2.86 
K156AR197P  33.3  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
60.40  
29.60  
10.00  
82.04 
 
100  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
50.31  
36.60  
13.09  
138.3 
 
200  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
0.00  
66.07  
33.93  
-- 
K156AR197Q  33.3  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
18.23  
69.57  
12.20  
3.2 
 
100  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
7.36  
77.52  
15.12  
1.4 
 
200  1254 
936.6 
699.6 
1.921  
2.571  
3.442
15.5  
30.7  
60.7
0.00  
83.4  
16.6  
-- 
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Figure 5.7 Oligomeric forms distribution of ∆68LexA mutants at different concentrations 
by DLS. 
The percentage of oligomeric states of the ∆68LexA proteins are presented at different 
concentrations. The percentage, oligomeric forms and concentrations are labelled. Monomeric, 
dimeric and tetrameric forms are presented in blue, red and green, respectively. Three different 
concentrations of proteins were tried for this study: 33.3 μM, 100 μM and 200 μM. 
K156AI196Y and K156AR197P mutants showed that predominantly monomeric proteins were 
present at 33.3 μM concentration solution. K156AR197P shows more monomeric proteins even 
at 100 μM concentration. Mostly oligomeric forms were found in other mutants at different 
concentrations. 
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Dimer dissociation constant (Kd) of Δ68LexAK156A for the dimeric form was estimated 
to be 2.18 μM (Table 5.1).  This means Δ68LexAK156A exists as a dimer at 33.3 μM 
concentration. This Kd value appeared to be close to the value reported by Kim and Little 
(1992), and the value reported for the C-terminal domain of the 434 phage repressor (Donner et 
al., 1998). This value is also close to another study performed previously in the current lab (~1 
μM) (Moya, 2006, unpublished data). Δ68LexAK156AR197Q mutant also showed Kd value <4 
μM (3.2 μM) and therefore, assumed as predominantly dimeric. Additionally, 
Δ68LexAK156AV195P would exist as a dimer even at lowest concentration tried (33.3 μM) 
since no monomeric protein was detected at that concentrations. On the other hand, 
Δ68LexAK156AI196Y would exist as a monomer at 33.3 μM concentration, since the Kd for the 
dimer was ~40 μM. Whereas, Δ68LexAK156AR197P showed a much higher Kd value of ~80 
μM at 33.3 μM concentration and can be certainly predicted that it would exist as monomers at 
low concentrations. Interestingly, Δ68LexAK156AR197P showed higher monomeric mass 
percentage than that of oligomeric even at 100 μM concentration.   
Therefore, it was confirmed that ∆68LexAK156AR197P was completely in the 
monomeric form, at least at concentrations as high as 100 μM. From the DLS experiment, we 
also found ∆68LexAK156AI196Y as predominantly monomeric at 33.3 μM but not at higher 
concentrations.  
 
 
5.4 Co-protease inhibition assay 
RecA is termed a co-protease because it acts indirectly in catalysis of LexA cleavage 
(Little, 1991). Cleavage of wild type LexA occurs in between residues Ala84 and Gly85. As a 
result, two fragments produced after the digestion of LexA are residues 1 to 84 and residues 85 
to 202. The two protein fragments can be detected on SDS protein gels. Therefore, the 
percentage of cleavage can be measured by analyzing band sizes and intensities of the intact 
and the cleaved products of wild type LexA from the SDS gel images. 
Allowing the RecA protein to cleave wild type LexA in a reaction solution is called a 
co-protease assay. The co-protease inhibition assay is different in the sense that an inhibitor, 
i.e., a LexA mutant, is added prior to wild type LexA in the reaction solution. Three trials of the 
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co-protease inhibition assay were performed with a time course, and the results are shown in 
Figure 5.8.  The band intensities and band areas of wild type LexA were analyzed with the 
Kodak GelLogic Image Analyzer. Figure 5.8 (A) shows the 2-hour time course of co-protease 
activity of LexA without any inhibitors, and samples from different times show that LexA was 
cleaved gradually with time.  
The band area of intact LexA decreased with time as the product band areas increased 
(Figure 5.8A). ~74% estimated cleavage of wt LexA was observed after 120 minutes of the 
reaction without any inhibitors. On the other hand, cleavage ranged from 5-17% when 
incubated with the inhibitor mutants (Figure 5.8B-F). The wild type LexA was cleaved 5%, 7%, 
13% and 17% in the presence of inhibitors ∆68LexAK156AV195P, ∆68LexAK156AR197Q, 
∆68LexAK156AI196Y and ∆68LexAK156AR197P, respectively. 
Notably, in the case of predominantly monomeric mutants (∆68LexAK156ARI196Y and 
∆68LexAK156AR197P), wild type LexA showed the most cleavage (15-17%) compared to the 
dimeric mutants.  However, the percentage is still significantly smaller than in the absence of 
any inhibitors (~74%). Therefore, it can be concluded that ∆68LexAK156AR197P inhibits 
RecA co-protease activity to some extend, which means it has some binding affinity to RecA as 
a monomer. Other mutants were better inhibitors than ∆68LexAK156AR197P in terms of the 
percentage of LexA cleavage. The ∆68LexAK156AI196Y mutant also showed good inhibitory 
affect, and this mutant was also found as predominantly monomeric at lower concentrations by 
DLS study. Actually visual observation of the band cleavages showed that 
∆68LexAK156AI196Y inhibited the LexA cleavage most though the band area measurement 
gave different results (13% wt LexA cleavage) (Figure 5.8D). This dispersion could be a result 
of errors during protein loading or gel staining variations. However, from the above results 
from monomeric protein determination and inhibition assay two mutants of LexA, 
∆68LexAK156AR197P and ∆68LexAK156AI196Y, were selected to perform co-crystallization 
trials.  
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Figure 5.8 Co-protease assay of RecA and co-protease inhibition assays by different LexA 
mutants. 
A) A typical co-protease timcourse assay of RecA. Cleavage of LexA is shown according to 
time (minutes). Wild type LexA cleaved gradually with time. The products were one His/1-84 
residue peptide chain and one 85-202 residue peptide chain. The wild type LexA band 
narrowed gradually according to time, whereas the peptide product bands thickened. B) A 
typical co-protease inhibition time course assay. Inhibitors were the ∆68LexAK156A mutants. 
RecA was incubated with the inhibitors prior to wild type LexA addition in the reaction 
mixture. Negative (-ve) control was performed without adding AMPPNP and positive (+ve) 
control was performed without adding inhibitors. C-F) Co-protease inhibition assay by the four 
∆68LexAK156A mutants. 13% Tricine-SDS polyacrylamide gels were run and the gels were 
stained with Coomassie Brilliant Blue R250. 8 μL of samples were loaded in each well. 
C: V195P D: I196Y
E: R197P F: R197Q
A 
 0′         30′        60′       90′      120′     
His/1-84 residue product of cleaved LexA 
RecA 
Wild type LexA 
85-202 residue product of cleaved LexA 
Mutant LexA (inhibitor) 
B 
0′       30′     60′      90′     120′   -ve      +ve  
His/1-84 residue product of cleaved LexA 
Wild type LexA 
RecA 
85-202 residue product of cleaved LexA 
 61 
 
5.5 Crystallization attempts 
Two most common methods of protein crystallization, known as the hanging drop 
method and sitting drop method, are in the vapor diffusion category. Proteins undergo slow 
precipitation during the crystallization method. Vapor diffusion facilitates this procedure by 
allowing the solvent to evaporate from the protein solution and diffuse to another solution (well 
solution). RecA protein needs ss/ds DNA molecules and ATP or an analogue to become active. 
RecA only interacts with LexA in its activated conformation. Therefore, our co-crystallization 
trial of RecA and LexA contained different lengths of ssDNA and ATP or an analogue. RecA is 
an ATPase family protein and uses divalent cations (such as Mg2+) during catalysis. Therefore, 
the crystallization solutions contained Mg2+ salts too. 
The approach here with the hanging drop method was to start with a wide range of 
conditions containing different precipitants and salts at different concentrations. Unfortunately, 
no co-crystals were possible to produce. Some tiny crystals were found in some of the random 
conditions, but those crystals were not good enough for diffraction. It was presumed that the co-
crystals should not resemble the size and shape of crystals of only the wild type RecA or mutant 
LexA alone. When repeated with the controls (LexA mutants and wild type RecA alone), the 
crystal sizes and shapes resembled the wild type crystals. In fact, no common trend in the 
crystallization conditions was identified. However, crystals were mostly found in solutions with 
12-20% PEG 3350 or K15 and HEPES-KOH buffers with pH ranging from 7.0 to 8.0. KAc, 
KCl, NaCl, etc., and MgCl2 or MgAc2 salts at concentrations that ranged from 5 mM to 60 mM 
produced some but tiny crytals.  
Crystallization kits with the sitting drop method were tried next to expand the range of 
conditions used. A total of 192 conditions were attempted with two different kits (The Pegs, 
The Classics, Nextal-Qiagen) each containing 96 kinds of solutions. The pattern of the results 
was similar to the hanging drop method. Some tiny crystals were obtained in some random 
conditions, but they were not reproducible and resembled the control crystals.  
Both the RecA and the LexA mutants were purified with a different buffer system 
without any chloride salt, mostly using NaAc or KAc instead of NaCl or KCl. Crystallization 
trials with these proteins in conditions without any chloride also did not produce usable 
crystals.  
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Chapter Six: Discussion 
6.1 Producing LexA dimer interface mutants  
The number of LexA molecules in non-induced E. coli is approximately 1300, including 
20% free and not bound to DNA (Sassanfar and Roberts, 1990). The C-terminal domains 
(CTD) of two LexA monomers interact with each other to form a dimer. DNA-bound LexA has 
an approximately 1000-fold higher dimerization stability compared to free LexA and the dimer 
dissociation constant (Kd) of LexA is in picomolar range (Mohana-Borges et al., 2000). 
Therefore, it is clear that LexA exists predominantly as a dimer under normal cellular 
conditions.  
Interestingly, studies on the RecA-LexA interaction suggest that LexA monomers bind 
RecA tighter than the dimer (Schnarr et al., 1988). An attempt was previously made in our lab 
and tried to provide support for this phenomenon (Moya, 2006). A non-cleavable LexA mutant, 
∆68K156AI196K, was purified, and analyses showed that it was predominantly monomeric in 
solution and inhibited LexA self-cleavage to some extend but not better than the dimeric mutant 
∆68K156AV195D. However, co-crystallization attempts of RecA and the monomeric LexA 
mutant were unsuccessful in that case. Therefore, this project was started to identify more 
monomeric LexA mutants and to co-crystallize with activated RecA. 
Crystal structure of LexA (Luo et al., 2001) revealed that residues from the anti-parallel 
β-11 strands and some other portions of the CTD make essential contacts that stabilize the 
dimeric form of LexA (Figure 4.2). A closer view of the anti-parallel β strands (Figure 4.2B-C) 
showed that residues from Val195 to Arg197 of β-11 participate the most in this interaction. 
Therefore, it was reasoned that, if mutations were made in this region, dimer formation would 
be possible to interrupt. For this purpose, four mutations were introduced in three consecutive 
residues (V195P, I196Y, R197P and R197Q). The mutated residues were selected because 
these might break down hydrogen bonds or produce steric hindrance between the two anti-
parallel β-11 strands. A K156A-mutated and N-terminally truncated (68 residues) LexA gene 
(∆68LexAK156A) was used to start the experiment as a template to introduce the other single 
mutations. The Lys156 to alanine mutation makes the LexA non-cleavable, and the N-
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terminally truncated version was used because this portion is not involved in any of the 
interactions or reactions in this study. 
 
6.2 ∆68LexAK156AR197P and ∆68LexAK156AI196Y are predominantly monomeric  
Molecular weight of protein oligomers is the sum of the individual monomers that 
produce the oligomers. Monomeric or oligomeric form of the protein in a solution can be 
determined thus by analyzing the size of the protein in solution. Two experimental methods 
were used in this study to determine the size of the LexA mutants. Size exclusion 
chromatography is a method that separates molecules according to size. It is a very efficient and 
popular method of purifying macromolecules like proteins. The method was used here as a tool 
to measure the size of the LexA mutants produced, which would ultimately indicate the forms 
(monomeric or oligomeric) of the mutants. Another method used for this purpose is dynamic 
light scattering (DLS). DLS measures the hydrodynamic radius of a molecule in a solution, and 
size of the molecule (MW) can be determined from that. Protein molecules can be used as 
samples for DLS, and the size of the protein can be precisely calculated from the results. 
Previously characterized LexA mutants, ∆68LexAK156A and ∆68LexAK156AI196K, 
were used as controls to compare the size exclusion chromatography elution profiles with the 
produced dimer interface mutants. ∆68LexAK156A and ∆68LexAK156AI196K were confirmed 
as predominantly dimeric and monomeric in solution, respectively (Moya, 2006). The results 
from the chromatography profiles showed that ∆68LexAK156AR197P appeared lately and 
resembles the size of monomeric proteins (Figure 5.4, 5.5). ∆68LexAK156AR197P and 
∆68LexAK156AI196K showed similar kind of elution profile. Both of the proteins were eluted 
with a larger volume than the other proteins and interestingly, a smaller peak was found just 
before the larger peak (Figure 5.4). This indicates that there might be some proteins present in 
oligomeric forms in the protein solution. The ∆68LexAK156AR197P mutant was also 
confirmed predominantly monomeric at both 33.3 μM and 100 μM from the DLS data (Figure 
5.6, 5.7). The ∆68LexAK156AI196Y mutant as well found as monomeric at 33.3 μM in the 
DLS data. However, it was close to the dimeric elution profile by size exclusion 
chromatography. Therefore, ∆68LexAK156AR197P was confirmed to be predominantly 
monomeric and ∆68LexAK156AI196Y was found monomeric at least at 33.3 μM. Interestingly, 
 64 
 
the ∆68LexAK156AV195P and ∆68LexAK156AR197Q LexA mutants showed even higher 
oligomeric mass percentages in solution compared to ∆68LexAK156A at 33.3 μM (Figure 5.6, 
5.7), which may be because the dimer interface mutations unexpectedly made the individual 
LexA subunits interact better with each other.  
Mutations V195P and R197Q reduced the Kd value (~2-4 μM) of the mutants and 
produced predominantly dimeric proteins in solution though those mutations were produced to 
break down the hydrogen bonds in the dimer interface. I197Y was assumed to produce steric 
hindrance between the strands in the interface and expectedly increase the Kd value to ~40 μM. 
Interestingly, R197P mutation increased the Kd value the most (~80 μM). Arg197 residue 
interacts not only with the Val195 of the opposite strand with two hydrogen bonds (4.2B) in the 
interface but it also interacts with Gly124 from the other monomer with two hydrogen bonds 
(Figure 4.2C). Actually this is the residue which shows most of the interactions (five hydrogen 
bonds, Figure 4.2B-C) in the dimer interface. It was possible that, replacing Arg195 with 
proline (P) broke down most of the interactions whereas glutamine (Q) could not. This might be 
the reason why the R197P mutation produced the most monomeric mutant. 
 
6.3 Dimer interface mutants of LexA bind RecA tightly 
Wild type LexA binds to the RecA nucleofilament at a Km of ~0.5 μM (Lin, 1988). 
However, non-cleavable LexA mutants, like K156A, interact with the active RecA filament 
tighter than the wild type (Slilaty and Little, 1987). Therefore, all of the mutants should bind to 
RecA tighter than wild type LexA. Affinities of the four LexA mutants for RecA was tried to 
determine.  
An experiment called a co-protease inhibition assay was designed where the non-
cleavable LexA dimer interface mutants were incubated with RecA in the reaction solution 
prior to addition of wild type LexA. LexA mutants would inhibit the co-protease activity if they 
bound to RecA tightly enough to block the binding site for LexA on the RecA nucleofilament. 
The results showed that both of the LexA mutants, ∆68LexAK156AR197P (17% wild type 
LexA cleavage) and ∆68LexAK156AI196Y (13% wt LexA cleavage), which were mostly 
monomeric in solution, inhibited the co-protease activity of RecA to a lesser extent than the 
dimers (5% and 7% of wt LexA cleavage by ∆68LexAK156AV195P and 
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∆68LexAK156AR197Q, respectively). This result contradicts with the hypothesis: monomeric 
LexA binds to RecA tighter than the dimer (Schnarr et al., 1988). However, a previous study 
performed in our lab with two different dimer interface mutants (V195D and I196K) also 
showed that the monomers interact poorly with RecA during the inhibitory assay. Though range 
of the percentage of wild type LexA cleavage in the presence of different inhibitors did not vary 
a lot (only 5-17%), it was significantly higher than the percentage of LexA cleavage in the 
absence of any inhibitors (~74%). The reason why the monomeric LexA mutants did not inhibit 
the cleavage of wild type LexA more than the dimers is unclear. Portions of the dimer interface 
of LexA is a hydrophobic region and exposing the region by mutations could cause significant 
changes in the conformation at the dimer interface site and interrupts the RecA-LexA 
interaction. In spite of this, the previous studies by Schnarr et al. (1988) were believed to be 
consistent and this study continued with the next attempts to co-crystallize the monomeric 
∆68LexAK156AR197P and ∆68LexAK156AI196Y proteins with RecA.    
 
6.4 LexA monomers cannot stabilize the active RecA nucleoprotein filament during 
crystal packing 
Protein crystallization is not always an easy task to perform. Sometimes it is not 
possible to crystallize even a single protein. Crystal structures of LexA (Luo et al., 2001) and 
inactive RecA (Story et al., 1991) were determined several years ago. The active structure of 
RecA was not solved in a conventional way because the active conformation is not stable 
during crystal packing. Instead, Chen et al. (2008) physically linked several RecA subunits (5 
or 6) to produce a fusion protein to stabilize the active conformation for crystallization and 
structure determination. Therefore, it is reasonable that attempts to co-crystallize RecA and 
LexA would be even harder, since the active conformation of RecA is hard to stabilize. In 
addition, co-crystallization of multiple proteins is always a difficult task. In this case, it was 
thought that since RecA is a co-protease enzyme that physically interacts with LexA, LexA 
would have a high binding affinity for RecA and that mutations in LexA should make LexA 
and RecA bind even tighter. Therefore, if a LexA mutant binds tightly to the activated RecA 
conformation, it may stabilize the active form and make it possible to produce co-crystals.   
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The active structure of RecA showed that every three nucleotides of ssDNA bind to one 
subunit of the RecA filament (Chen et al., 2008). Therefore, the length of ssDNA should limit 
the size of the nucleoprotein filament. Because of this, different sized DNA molecules were 
chosen. There is another problem with RecA polymerization, since RecA polymerizes 
indefinitely if not blocked. Although it was thought that the DNA would limit the size of the 
nucleoprotein filament, it may not be sufficient. Therefore, DNA molecules were designed 
having a biotin group at the 5′ or 3′ end of the DNA. The biotin should block the self-
polymerization of RecA. The concentrations of ATP or analogs (1 mM) and the ssDNA (1 mM) 
were fixed, and the types of ATP analogs and ssDNA were varied. Different types and 
concentrations of salts and precipitants were also tried. Unfortunately, no co-crystals of the 
activated RecA and LexA mutants were possible to obtain. As mentioned in the results section, 
some tiny crystals were found in random conditions without any identifiable trend. When 
compared with the LexA and RecA crystals alone, the shapes and sizes of the crystals were 
found similar. It was reasoned that if complex crystals were formed, they would have been 
completely different in size and shape from the crystals of LexA or RecA alone. Therefore, it 
can be concluded from this study that the developed monomeric LexA mutants do not have the 
ability to stabilize the active form of wt RecA and therefore cannot be co-crystallized.  
 
6.5 Possible future works on LexA-RecA interactions 
Two separate attempts in the current lab, including this work and by Moya (2006), on 
co-crystallization of RecA and LexA appeared unsuccessful. Therefore, this is the time to think 
about an alternative way to reveal the interactions between LexA and RecA and the details of 
the mechanisms of co-protease activity of RecA. It seems crystallization of RecA and LexA or 
its mutants together is too hard to accomplish. However, some of the options were not tried in 
these experiments what can be explored for the future studies on this topic. It was mentioned 
earlier that Chen et al. (2008) provided the structural details of the active RecA filament 
(Figure 2.6) and elucidated the mechanism of the homologous recombination. A quite 
interesting strategy was applied to obtain the RecA active filament and to limit the length of the 
filament. Multiple copies of the E. coli recA gene, corresponding to 1-335 residues, were fused 
in to a single reading frame with intervening 14-amino-acid linkers. To prevent the fusion 
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protein or concatemer from polymerizing, the N-terminal RecA had a deletion of 1-30 amino 
acids and the C-terminal RecA had Cys117Met, Ser118Val and Gln119Arg mutations. The 
fusion protein produced crystals with different length of ss/dsDNA, such as 15 nt long ((dT)15) 
for 5 subunits RecA chain (termed RecA5).  
From the current study on the crystallization of LexA dimer interface mutants and 
RecA, it can be understood that these attempts are difficult to accomplish. On the other hand, 
there are reasons to believe that, the RecA fusion protein by Chen et al. (2008) can be applied 
to these attempts with the dimer interface monomeric mutants of LexA and even with the non-
cleavable dimeric LexA as the fused RecA filament was proved to be crystallized in active form 
with different lengths of DNAs and with ATP or analogs. The fusion protein can be purified as 
described by Chen et al. (2008). The co-protease and co-protease inhibition assays with the 
RecA fusion protein can be performed. Any crystallization attempts of the LexA protein with 
the RecA fusion protein (from Chen et al., 2008) have not been reported yet. Therefore, there 
are opportunities to try the noncleavable and dimer interface mutants of LexA to co-crystallize 
with RecA fusion protein. Different length of the fused RecA chain can also be tried.  
We mentioned earlier that VanLoock et al. (2003b) applied the iterative helical real 
space reconstruction (IHRSR) method using electron microscopy (EM) reconstruction of RecA-
ATP-LexA-DNA complex (Egelman and Stasiak, 1993; VanLoock et al., 2003b) to compare 
the difference of fitting of inactive crystal structure of RecA (Story et al., 1992) and the model 
of RecA active filament (VanLoock et al., 2003a). Results showed that RecA active model fit 
better when the active (modelled) and inactive (crystal structure) RecA were docked on the 
RecA-ATP-LexA-DNA complex (Figure 2.9). VanLoock et al. had to use a model (VanLoock 
et al., 2003a) for the RecA active filament, as the crystal structure of active RecA was not 
available at that time. It would be interesting if the now-available active crystal structure of 
RecA was docked on the EM reconstruction complex to see how it fits. If the first attempt 
mentioned here is not possible to achieve, this study would be necessary to have some idea 
about the interactions of LexA and RecA. 
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